EXHIBIT 99.2

   

INDEX TO FINANCIAL STATEMENTS

 

 

 

 

Page

RENERGEN LIMITED

Audited Consolidated Financial Statements

 

 

Report of Independent Registered Public Accounting Firm (PCAOB ID 1368)

 

2

Consolidated Statement of Financial Position as of February 28, 2025 and February 29, 2024

 

3

Consolidated Statement of Profit or Loss and Other Comprehensive Loss for the years ended February 28, 2025 and February 29, 2024

 

4

Consolidated Statement of Changes in Equity for the years ended February 28, 2025 and February 29, 2024

 

5

Consolidated Statement of Cash Flows for the years ended February 28, 2025 and February 29, 2024

 

6

Notes to the Consolidated Financial Statements

 

7

 

 
1

 

 

Report of Independent Registered Public Accounting Firm (PCAOB ID 1368)

 

To the Shareholders of Renergen Limited and its subsidiaries

 

Tel: +27 011 488 1700

Fax: +27 010 060 7000

www.bdo.co.za

 

Wanderers Office Park

52 Corlett Drive

Illovo, 2196

 

 

 

 

 

 

 

Private Bag X60500

Houghton, 2041

South Africa

 

Report of Independent Registered Public Accounting Firm

 

Shareholders and Board of Directors

Renergen Limited

Johannesburg, South Africa

 

Opinion on the Consolidated Financial Statements

 

We have audited the consolidated financial statements of Renergen Limited (the “Company”, together with its subsidiaries, “the Group”), which comprise the consolidated statements of financial position as at 28 February 2025, and the consolidated statements of profit or loss and other comprehensive loss, consolidated statements of changes in equity and the consolidated statements of cash flows for the year then ended, and notes to the consolidated financial statements, including material accounting policy information.

 

In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as at 28 February 2025, and its consolidated financial performance and consolidated cash flows for the year then ended in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board and the requirements of the Companies Act of South Africa.

 

Basis for Opinion

 

We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the Independent Regulatory Board for Auditors’ Code of Professional Conduct for Registered Auditors (IRBA Code) and other independence requirements applicable to performing audits of financial statements in South Africa. We have fulfilled our other ethical responsibilities in accordance with the IRBA Code and in accordance with other ethical requirements applicable to performing audits in South Africa. The IRBA Code is consistent with the corresponding sections of the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International Independence Standards). We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

Material uncertainty related to going concern

 

We draw attention to note 36 to the consolidated financial statements, which indicates that the Group’s ability to conclude the funding initiatives outlined in note 36 within the Assessment Period, to remedy the Default Events within the times set out in the DFC waiver and ability to secure regulatory and other approvals required to conclude the Nasdaq IPO and other funding initiatives highlighted during the period ending 30 April 2026, represent material uncertainties that may cast significant doubt on the Group’s ability to continue as a going concern, and therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business.

 

We have served as the auditor of Renergen Limited since 2022.

 

/s/ BDO South Africa Inc.

 

BDO South Africa Incorporated

 

Johannesburg, South Africa

May 27, 2025

  

BDO South Africa Incorporated

Registration number: 1995/002310/21

Practice number: 905526

VAT number: 4910148685

Chief Executive Officer: LD Mokoena

A full list of all company directors is available on www.bdo.co.za

 

The company’s principal place of business is at The Wanderers Office Park, 52 Corlett Drive, Illovo, Johannesburg where a list of directors’ names is available for inspection. BDO South Africa Incorporated, a South African personal liability company, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.

 

 
2

 

 

Consolidated Statement of Financial Position

 

as at 28 February

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

ASSETS

 

Non-current assets

 

 

 

 

 

2236021

 

 

 

2110001

 

Property, plant and equipment1

 

 

3

 

 

 

2009373

 

 

 

1877132

 

Intangible assets

 

 

4

 

 

 

24300

 

 

 

82212

 

Deferred taxation

 

 

6

 

 

 

141586

 

 

 

90435

 

Restricted cash

 

 

7

 

 

 

23079

 

 

 

17243

 

Finance lease receivables

 

 

8

 

 

 

37683

 

 

 

42979

 

Current assets

 

 

 

 

 

 

113153

 

 

 

599126

 

Inventory

 

 

 

 

 

3 198

 

 

2 073

 

Restricted cash

 

 

7

 

 

 

49497

 

 

 

87300

 

Finance lease receivables

 

 

8

 

 

6 116

 

 

5 969

 

Trade and other receivables

 

 

9

 

 

 

26025

 

 

 

32709

 

Cash and cash equivalents

 

 

10

 

 

 

28317

 

 

 

471075

 

Total assets

 

 

 

 

 

 

2349174

 

 

 

2709127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EQUITY AND LIABILITIES

Stated capital

 

 

11

 

 

 

1210302

 

 

 

1170059

 

Share-based payments reserve

 

 

12

 

 

 

26318

 

 

 

26445

 

Other reserves

 

 

26

 

 

 

946

 

 

 

628

 

Accumulated (loss)/profit

 

 

 

 

 

 

(198934 )

 

 

46515

 

Equity attributable to equity holders of Renergen

 

 

 

 

 

 

1038632

 

 

 

1243647

 

Non-controlling interest (“NCI”)

 

 

13.2

 

 

 

75977

 

 

 

77456

 

Total equity

 

 

 

 

 

 

1114609

 

 

 

1321103

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES

Non-current liabilities

 

 

 

 

 

 

122646

 

 

 

816467

 

Borrowings

 

 

14

 

 

 

53205

 

 

 

748659

 

Lease liabilities

 

 

15

 

 

 

10011

 

 

 

11613

 

Deferred revenue

 

 

16

 

 

 

15095

 

 

 

15743

 

Provisions

 

 

17

 

 

 

44335

 

 

 

40452

 

Current liabilities

 

 

 

 

 

 

1111919

 

 

 

571557

 

Borrowings

 

 

14

 

 

 

1013737

 

 

 

487470

 

Trade and other payables

 

 

18

 

 

 

96413

 

 

 

82272

 

Lease liabilities

 

 

15

 

 

1 769

 

 

1 815

 

Total liabilities

 

 

 

 

 

 

1234565

 

 

 

1388024

 

Total equity and liabilities

 

 

 

 

 

 

2349174

 

 

 

2709127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1. Includes right-of-use assets as presented in note 3.

 

 

 

 

 

 

 

 

 

 

 

 

 

 
3

 

 

Consolidated Statement of Changes in Equity

 

for the year ended 28 February

 

Figures in Rand Thousands

 

Notes

 

 

Stated

capital

 

 

Share-based

payments

reserve

 

 

Revaluation

reserve

 

 

Foreign

currency

translation

reserve

 

 

Accumulated

(loss)/profit

 

 

Total equity

attributable to

equity holders of

Renergen Limited

 

 

Non-controlling

interest (“NCI”)

 

 

Total equity

 

Balance at 1 March 2023

 

 

 

 

 

1134750

 

 

 

21099

 

 

 

598

 

 

 

 

 

 

(316243 )

 

 

840204

 

 

 

 

 

 

840204

 

Loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(110273 )

 

 

(110273 )

 

 

481

 

 

 

(109792 )

Other comprehensive income for the year

 

 

 

 

 

 

 

 

 

 

 

104

 

 

 

(74 )

 

 

 

 

 

30

 

 

 

6

 

 

 

36

 

Total comprehensive loss for the year

 

 

 

 

 

 

 

 

 

 

 

104

 

 

 

(74 )

 

 

(110273 )

 

 

(110243 )

 

 

487

 

 

 

(109756 )

Sale of interest in Tetra4

 

 

13.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

473031

 

 

 

473031

 

 

 

76969

 

 

 

550000

 

Issue of shares

 

 

11

 

 

 

35309

 

 

 

(2728 )

 

 

 

 

 

 

 

 

 

 

 

32581

 

 

 

 

 

 

32581

 

Share-based payments expense

 

 

12

 

 

 

 

 

8 074

 

 

 

 

 

 

 

 

 

 

 

8 074

 

 

 

 

 

8 074

 

Balance at 29 February 2024

 

 

 

 

 

 

1170059

 

 

 

26445

 

 

 

702

 

 

 

(74 )

 

 

46515

 

 

 

1243647

 

 

 

77456

 

 

 

1321103

 

Loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(236120 )

 

 

(236120 )

 

 

(10808 )

 

 

(246928 )

Other comprehensive income for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

318

 

 

 

 

 

 

318

 

 

 

 

 

 

318

 

Total comprehensive loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

318

 

 

 

(236120 )

 

 

(235802 )

 

 

(10808 )

 

 

(246610 )

NCI share of equity contribution

 

 

13.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9329

)

 

 

(9329

)

 

 

9329

 

 

 

 

Issue of shares

 

 

11

 

 

 

42558

 

 

 

(3242 )

 

 

 

 

 

 

 

 

 

 

 

39316

 

 

 

 

 

 

39316

 

Share issue costs

 

 

11

 

 

 

(2315 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2315 )

 

 

 

 

 

(2315 )

Share-based payments expense

 

 

12

 

 

 

 

 

3 115

 

 

 

 

 

 

 

 

 

 

 

3115

 

 

 

 

 

3 115

 

Balance at 28 February 2025

 

 

 

 

 

 

1210302

 

 

 

26318

 

 

 

702

 

 

 

244

 

 

 

(198934

)

 

 

1038632

 

 

 

75977

 

 

 

1114609

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

 

 

 

 

 

11

 

 

 

12

 

 

 

26.1

 

 

 

26.2

 

 

 

 

 

 

 

 

 

 

 

13.2

 

 

 

 

 

 

 
4

 

 

Consolidated Statement of Profit or Loss and Other Comprehensive Loss

 

for the year ended 28 February

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Revenue

 

 

19

 

 

 

52113

 

 

 

28952

 

Cost of sales

 

 

20

 

 

 

(80173 )

 

 

(18885 )

Gross (loss)/profit

 

 

 

 

 

 

(28060 )

 

 

10067

 

Other operating income

 

 

21

 

 

 

227

 

 

9 778

 

Share-based payments expense

 

 

12

 

 

 

(3115 )

 

 

(8074 )

Other operating expenses

 

 

22

 

 

 

(196796 )

 

 

(146868 )

Operating loss

 

 

 

 

 

 

(227744 )

 

 

(135097 )

Interest income

 

 

23

 

 

 

10784

 

 

 

10853

 

Interest expense and imputed interest

 

 

24

 

 

 

(81119 )

 

 

(22747 )

Loss before taxation

 

 

 

 

 

 

(298079 )

 

 

(146991 )

Taxation

 

 

25

 

 

 

51151

 

 

 

37199

 

Loss for the year

 

 

 

 

 

 

(246928 )

 

 

(109792 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income:

 

Items that may be reclassified to profit or loss in subsequent periods:

 

 

 

 

 

 

 

 

 

 

 

 

Exchange differences on translation of foreign operation

 

 

26.2

 

 

 

318

 

 

 

(74 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Items that may not be reclassified to profit or loss in subsequent periods:

 

 

 

 

 

 

 

 

 

 

 

 

Revaluation of properties

 

 

 

 

 

 

 

 

 

110

 

Other comprehensive income for the year

 

 

 

 

 

 

318

 

 

 

36

 

Total comprehensive loss for the year

 

 

 

 

 

 

(246610 )

 

 

(109756 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss attributable to:

Owners of Renergen

 

 

 

 

 

 

(236120 )

 

 

(110273 )

Non-controlling interest

 

 

 

 

 

 

(10808 )

 

 

481

 

Loss for the year

 

 

 

 

 

 

(246928 )

 

 

(109792 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss attributable to:

Owners of Renergen

 

 

 

 

 

 

(235802 )

 

 

(110243 )

Non-controlling interest

 

 

 

 

 

 

(10808 )

 

 

487

 

Total comprehensive loss for the year

 

 

 

 

 

 

(246610 )

 

 

(109756 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per ordinary share

Basic and diluted loss per share (cents)

 

 

33

 

 

 

(159.10 )

 

 

(75.10 )

 

 
5

 

 

Consolidated Statement of Cash Flows

 

for the year ended 28 February

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Cash flows used in operating activities

 

 

 

 

 

(139854 )

 

 

(53847

)

Cash used in operations

 

 

27

 

 

 

(150638 )

 

 

(64700

)

Interest received

 

 

23

 

 

 

10784

 

 

 

10853

 

Tax paid

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows used in investing activities

 

 

 

 

 

 

(99936 )

 

 

(303740

)

Investment in property, plant and equipment

 

 

3

 

 

 

(105481 )

 

 

(221874 )

Disposal of property, plant and equipment

 

 

3

 

 

 

220

 

 

 

 

Investment in intangible assets

 

 

4

 

 

 

(26642 )

 

 

(81866 )

Movement in restricted cash

 

 

7

 

 

 

31967

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash flows (used in)/from financing activities

 

 

 

 

 

 

(202956 )

 

 

773717

 

Ordinary shares issued for cash

 

 

11

 

 

 

39316

 

 

 

32581

 

Share issue costs

 

 

11

 

 

 

 

 

 

(2208 )

Proceeds from part-disposal of interest in Tetra4

 

 

13.2

 

 

 

 

 

 

550000

 

Repayment of borrowings – capital

 

 

28

 

 

 

(375311 )

 

 

(105245 )

Repayment of interest on borrowings

 

 

28

 

 

 

(92156 )

 

 

(69999 )

Interest paid on leasing and other arrangements

 

 

24

 

 

 

(2797 )

 

 

(3683 )

Proceeds from borrowings

 

 

28

 

 

 

229640

 

 

 

373972

 

Payment of lease liabilities – capital

 

 

15

 

 

 

(1648 )

 

 

(1701 )

Total cash movement for the year

 

 

 

 

 

 

(442746 )

 

 

416130

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the year

 

 

10

 

 

 

471075

 

 

 

55705

 

Effects of exchange rate changes on cash and cash equivalents

 

 

 

 

 

 

(12 )

 

 

(760 )

Total cash and cash equivalents at the end of the year

 

 

10

 

 

 

28317

 

 

 

471075

 

 

 
6

 

 

Renergen Limited

(Registration number 2014/195093/06)

Financial Statements for the years ended 28 February 2025 and 29 February 2024

 

Notes to the Consolidated Financial Statements

 

Material Accounting Policies

 

for the year ended 28 February

 

1. BASIS OF PREPARATION

 

Renergen Limited (“the Company”, together with its subsidiaries, “the Group”), is a company incorporated in South Africa and is listed on the Johannesburg Stock Exchange and the Australian Securities Exchange. The Group is focused on alternative and renewable energy in South Africa and sub-Saharan Africa. Further details on the operation of Group companies are provided in note 5.

 

The consolidated financial statements for the year ended 28 February 2025 have been prepared in accordance with IFRS Accounting Standards, the South African Financial Reporting Requirements, the JSE Listings Requirements and in a manner required by the Companies Act. The accounting policies applied in the preparation of these consolidated financial statements are consistent in all material respects with those used in the prior financial year, except for the adoption of new standards, interpretations and amendments to published standards which became effective for the first time for the financial year ended 28 February 2025. Note 2 discloses the impact of new standards, interpretations and amendments to published standards on the consolidated financial statements of the Group.

 

These consolidated financial statements have been prepared under the historical cost convention except for land that is carried at a revalued amount; are presented in the functional currency of the Company and presentation currency of the Group, being South African Rand (“Rand”); and are rounded to the nearest thousand (“R’000”), except where otherwise stated.

 

Going concern

 

The consolidated financial statements have been prepared on the basis of accounting policies applicable to a going concern. This basis presumes that funds will be available to finance future operations and that the realisation of assets and settlement of liabilities, contingent obligations and commitments will occur in the ordinary course of business. Refer to note 36 for further disclosures on going concern matters.

 

1.1 CONSOLIDATION

 

Basis of consolidation

 

The consolidated financial statements incorporate the financial statements of the Company and its subsidiaries which are controlled by the Company.

 

Consolidation of subsidiaries

 

All intercompany transactions and balances between the Company and its subsidiaries have been eliminated on consolidation.

 

 
7

 

 

Changes in ownership interest without a loss of control

 

An increase or decrease in the Company’s ownership interest that does not result in a loss of control of a subsidiary is accounted for as an equity transaction. The carrying amounts of the controlling and NCI are adjusted to reflect changes in their relative interests in the subsidiary. The Company recognises directly in equity the difference between the amount by which the NCI are adjusted and the fair value of the consideration paid or received, and attributes this difference to the owners of the Company (the controlling interest). No changes in the subsidiary’s assets or liabilities are recognised in a transaction in which the Company increases or decreases its ownership interest in a subsidiary that it already controls. Similarly, no gain or loss is recognised in such transactions.

 

1.2 SIGNIFICANT JUDGEMENTS AND SOURCES OF ESTIMATION UNCERTAINTY

 

The Group makes certain estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.

 

JUDGEMENTS

 

Any judgement about the future is based on information available at the time at which the judgement is made. Subsequent events may result in outcomes that are inconsistent with judgements that were reasonable at the time they were made.

 

Going concern (note 36)

 

Management’s assessment of the Group’s ability to continue as a going concern involved making a judgement about the Group’s ability to achieve profitability which is dependent on a number of factors including securing requisite funding to complete Phase 1C of the VGP in order to achieve nameplate capacity. Further disclosures of initiatives under way to secure this funding, and of the material uncertainties which may cast doubt on the ability of the Group to continue as a going concern, are outlined in note 36.

 

Recognition of deferred tax assets (notes 1.8 and 6)

 

After determining that future taxable income will be available against which deductible temporary differences and tax losses carried forward can be utilised, Management exercises its judgement to further establish a percentage to limit the amount of the deferred tax asset that can be recognised.

 

Determination of a lease term (notes 1.9 and 8)

 

In determining the lease term, Management considers all facts and circumstances that create an economic incentive to exercise an extension option, or not to exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or not terminated). Management has applied judgement to conclude lessees will not exercise the purchase option (available after 18 months from lease commencement date) or the lease extension option (five years) applicable to the leases disclosed in note 8, and has therefore accounted for the lease term as eight years. In making this judgement management considered the potential disruption to the lessees’ operations (with respect to the lease termination) and changes in technology which may discourage the extension of the leases.The assessment is reviewed if a significant event or a significant change in circumstances occurs which affects this assessment. A material uncertainty still remains whether the lessees will exercise the extension or purchase option which would significantly impact the finance lease receivables recognised by the Group.

 

Exploration and development costs (notes 1.4 and 4)

 

The application of the Group’s accounting policy for exploration and development costs requires judgement to determine whether it is likely that future economic benefits are likely, from either future exploitation or sale, or whether activities have reached a stage which permits a reasonable assessment of the existence of reserves. In applying this judgement, Management considers the outcomes from the exploration campaigns of the Group and relies on Reserve and Evaluation Reports prepared by independent sub-surface consultants in assessing the reserves and resources and associated economics of the VGP. This process determines whether exploration and development costs are capitalised or are otherwise transferred to property, plant and equipment once the commercial viability of the extraction of LNG is demonstrable.

 

 
8

 

 

ESTIMATES AND ASSUMPTIONS

 

Reserves and resources (notes 1.4 and 4)

 

The determination of reserves and resources is an estimation process that involves varying degrees of uncertainty depending on how the reserves and resources are classified. Reserves and resources could differ depending on significant changes in the factors or assumptions used in the estimation process. These factors could include:

 

changes in proved and probable gas reserves;

differences in pricing assumptions;

unforeseen operational issues; and

changes in capital, operating, processing and other costs, discount rates and foreign exchange rates.

 

The Group relies on independent sub-surface consultants in assessing the reserves and resources.

 

Impairment of non-financial assets (note 4)

 

In assessing impairment, Management estimates the recoverable amount of each asset or cash-generating unit (“CGU”) based on expected future cash flows and uses an interest rate to discount them. Estimation uncertainty relates to assumptions about reserves and resources, commodity prices, future operating and capital costs, interest rates, exchange rates, inflation rates and the determination of a suitable discount rate.

 

Reserves and resources – the Group relies on independent sub-surface consultants in assessing the reserves and resources which are used to determine projected cash flows.

 

Commodity prices, interest rates, inflation rates and exchange rates – these are benchmarked against external sources of information. Where existing sales contracts are in place, the effects of such contracts are considered in determining future cash flows.

 

Future operating and capital costs – operating costs and capital expenditure are based on financial budgets covering a three-year period. Cash flow projections beyond three years are based on the life-of-asset plan, as applicable, and internal management forecasts. Cost assumptions incorporate management experience and expectations.

 

Useful lives for property, plant and equipment and intangible assets (notes 1.3, 1.4 and 3)

 

In determining the useful life of items of property, plant and equipment, Management considers the expected usage of assets, expected physical wear and tear, legal or similar limits of assets and past experience of the Group with similar assets. Any change in management’s estimate of the useful lives of assets would impact the depreciation charge.

 

Provision for environmental rehabilitation (notes 1.10 and 17)

 

Management relies on environmental experts to assist with the determination of rehabilitation obligations. The determination of rehabilitation costs requires estimates and assumptions to be made around the relevant regulatory framework, the magnitude of the possible disturbance and the timing, extent and costs of the required closure and rehabilitation activities. Most of these rehabilitation and decommissioning events are expected to take place in the future and the current estimated requirements and costs that will have to be met when the restoration event occurs are inherently uncertain and could materially change over time.

 

In calculating the appropriate provision for the expected restoration, rehabilitation or decommissioning obligations, cost estimates of the future potential cash outflows based on current studies of the expected rehabilitation activities and timing thereof, are prepared.

 

 
9

 

 

As the actual future costs can differ from the estimates due to the changes in laws, regulations, technology, costs and timing, the provisions including the estimates and assumptions contained therein are reviewed annually by Management.

 

Taxation (notes 6 and 25)

 

Taxation of oil and gas companies is highly complex and the determination of the Group’s tax position involves an estimation of tax outcomes which include special allowances that would be available to the Group, amongst other factors. Where such outcomes are different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

 

Fair value measurement (notes 3, 4 and 32)

 

The assessment of fair value is principally used in accounting for impairment testing, the disclosure of fair values of certain financial instruments and the valuation of land. The Group Executive Committee oversees material assessments of fair values applicable to the Group’s financial instruments and non-financial assets.

 

Management uses various valuation techniques to determine the fair value of financial instruments (where active market quotes are not available) and non-financial assets. This involves developing estimates and assumptions consistent with how market participants would price the instrument. Management bases its assumptions on observable data as far as possible, but this is not always available. In that case, Management uses the best information available. Estimated fair values may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date.

 

1.3 PROPERTY, PLANT AND EQUIPMENT

 

Property, plant and equipment is initially measured at cost including an estimate of the costs of decommissioning the asset. Cost includes all of the expenditure which is directly attributable to the acquisition or construction of the asset. For qualifying assets, costs includes capitalised borrowing costs (note 1.15).

 

Property, plant and equipment (excluding land which is carried under the revaluation model) is subsequently measured at cost less accumulated depreciation and accumulated impairment losses.

 

Expenditure incurred subsequently for major services, additions to or replacements of parts of property, plant and equipment is capitalised if it is probable that future economic benefits associated with the expenditure will flow to the Group and the cost can be measured reliably. The carrying amount of any component accounted for as a separate asset is derecognised when replaced. Day-to-day servicing costs are included in profit or loss during the year in which they are incurred.

 

Depreciation is charged to write off the cost of assets over their estimated useful lives, using the straight-line method. Each part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately. Assets under construction are not depreciated as they are not ready and available for the use as intended by Management. Leased assets are depreciated over the shorter of the asset’s useful life and the lease term. When a purchase option is included in the lease terms, the asset is depreciated over its estimated useful life.

 

Land is carried under the revaluation model and revalued with sufficient frequency to ensure that at any point in time the carrying amount still approximates fair value. A revaluation surplus is recorded in other comprehensive income or loss and credited to the revaluation reserve in equity. However, to the extent that it reverses a revaluation deficit of the same asset previously recognised in profit or loss, the increase is recognised in profit and loss. A revaluation deficit is recognised in the statement of profit or loss, except to the extent that it off-sets an existing surplus on the same asset recognised in the revaluation reserve. Upon disposal any revaluation surplus relating to the revalued land being sold is transferred to the accumulated loss.

 

 
10

 

 

The useful lives of items of property, plant and equipment have been assessed as follows:

 

ITEM

DEPRECIATION METHOD

USEFUL LIFE

Development asset

Units of production

Not applicable

Rehabilitation asset

Straight line

20 years

Furniture and fixtures

Straight line

6 years

IT equipment

Straight line

3 years

Assets under construction

Not applicable

Not applicable

Motor vehicles

Straight line

5 years

Office equipment

Straight line

6 years

Plant and machinery

Straight line

5 – 20 years

Office building

Straight line

10 years

Leasehold improvements – furniture and fixtures

Straight line

6 years

Leasehold improvements – office equipment

Straight line

6 years

Right-of-use asset – motor vehicles

Straight line

4 – 6 years

Right-of-use asset – head office building

Straight line

5.75 years

Land

Not depreciated

Not applicable

 

The residual value, useful life and depreciation method of each asset are reviewed at the end of each reporting year. If the expectations differ from previous estimates, the change is accounted for prospectively as a change in accounting estimate.

 

The depreciation charge for each year is recognised in profit or loss within cost of sales and other operating expenses.

 

Impairment tests are performed on property, plant and equipment when there is an indicator that they may be impaired. The impairment tests are performed as set out in note 1.5.

 

Fair value movements on the land are recognised, net of tax, in other comprehensive income or loss on the statement of comprehensive income (or loss) and accumulated in the revaluation reserve in the statement of changes in equity. The reserve balance will be transferred to the accumulated loss upon disposal of the land.

 

An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits are expected from its continued use or disposal.

 

1.4 INTANGIBLE ASSETS

 

Intangible assets are initially recognised at cost. Following initial recognition intangible assets are measured at cost less any accumulated amortisation and accumulated impairment losses.

 

Exploration and development costs

 

Expenditures incurred in the exploration and development of natural gas reserves are capitalised to intangible assets. Prior to capitalisation the Group assesses the degree to which the expenditures incurred in the exploration phase can be associated with finding natural gas.

 

 
11

 

 

The amortisation period and the amortisation method for intangible assets is as follows and are reviewed annually:

 

ITEM

AMORTISATION METHOD

Exploration and development costs

Units of production

 

Amortisation of exploration and development costs will commence upon the start of production at which point they are transferred to property, plant and equipment (“PPE”) as development assets.

 

The impairment tests are performed as set out in note 1.5.

 

INTERNALLY GENERATED INTANGIBLE ASSETS

 

Expenditure on internally developed intangible assets is capitalised when the Group can demonstrate:

 

the technical feasibility of completing the intangible asset so that the asset will be available for use or sale;

its intention to complete, and its ability and intention to use or sell the asset;

how the asset will generate future economic benefits;

the availability of resources to complete the asset; and

the ability to measure reliably the expenditure during development.

 

Following initial recognition of the intangible asset, the asset is carried at cost less any accumulated amortisation and accumulated impairment losses. Amortisation of the asset begins when development is complete and the asset is available for use. It is amortised over the period of expected future benefit. Amortisation is recorded in other operating expenses within profit or loss. During the period of development, the asset is tested for impairment annually.

 

Development expenditure not satisfying the above criteria and expenditure on the research phase of internal projects are recognised in profit or loss as incurred.

 

The Group’s internally generated intangible assets include development costs attributable to Cryo-VaccTM and the Helium Token System.

 

1.5 IMPAIRMENT OF NON-FINANCIAL ASSETS

 

Non-financial assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell), the asset is written down accordingly.

 

 
12

 

 

In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. Future cash flows are based on detailed budgets and forecast calculations which generally cover a period of three years. For longer periods a long-term growth rate is calculated and applied to projected future cash flows after the third year. In determining fair value less costs of disposal, recent market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used.

 

Where it is not possible to estimate the recoverable amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there are separately identifiable cash flows: its CGUs.

 

Impairment charges are included in profit or loss within other operating expenses, except to the extent they reverse gains previously recognised in other comprehensive income or loss.

 

A previously recognised impairment charge is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment charge was recognised. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment charge been recognised for the asset in prior years. Such a reversal is recognised in profit or loss unless the asset is carried at a revalued amount, in which case the reversal is treated as a revaluation increase.

 

1.6 FINANCIAL INSTRUMENTS

 

Financial assets and financial liabilities are recognised on trade date when the Group becomes a party to the contractual provisions of the financial instrument.

 

Financial assets are derecognised when the contractual rights to the cash flows from the financial asset expire, or when the financial asset and substantially all the risks and rewards are transferred. A financial liability is derecognised when it is extinguished, discharged, cancelled or expires.

 

FINANCIAL ASSETS

 

Classification

 

The Group classifies its financial assets as financial assets at amortised cost. At 28 February 2025 and 29 February 2024 the Group did not have financial assets at fair value through profit or loss (“FVTPL”) or at fair value through other comprehensive income (“FVOCI”).

 

Financial assets at amortised cost

 

These assets arise principally from the provision of products to customers (e.g. trade receivables), but also incorporate other types of financial assets where the objective is to hold these assets in order to collect contractual cash flows and the contractual cash flows are solely payments of principal and interest. Except for those trade receivables measured at the transaction price in accordance with IFRS 15, all financial assets are initially measured at fair value adjusted for transaction costs (where applicable), that are directly attributable to their acquisition or issue, and are subsequently carried at amortised cost using the effective interest rate method, less an allowance for impairment.

 

The Group’s financial assets measured at amortised cost comprise trade and other receivables (note 9), restricted cash (note 7) and cash and cash equivalents (note 10) in the consolidated statement of financial position.

 

All income and expenses relating to financial assets that are recognised in profit or loss are presented within interest expense and interest income, except for the impairment of financial assets which is presented within other operating expenses.

 

Trade and other receivables

 

The Group’s trade receivables do not contain a significant financing component and are accounted for as outlined above.

 

Cash and cash equivalents

 

In the consolidated statement of financial position and the consolidated statement of cash flows, cash and cash equivalents include cash on hand and at banks, short-term deposits and other short-term highly liquid investments with original maturities of three months or less. The Group does not have overdraft facilities.

 

 
13

 

 

Restricted cash

 

The Group has cash deposits in call accounts that have been ring-fenced. Access to such accounts is restricted and requires authorisation of third-party counterparties. These cash deposits consist of funds which will be used for environmental rehabilitation and the settlement of debt obligations (due within a six-month period at any given time) under the Finance Agreements with the US International Development Finance Corporation (“DFC”) and Industrial Development Corporation (“IDC”) (see note 14). This cash is not treated as cash and cash equivalents.

 

Impairment of financial assets

 

Trade receivables and finance lease receivables

 

The Directors of the Company estimate the loss allowance on trade receivables and finance lease receivables at the end of the reporting period at an amount equal to lifetime expected credit losses (“ECLs”) using the simplified approach as the lessees are also the Group’s only trade debtors. The expected loss rates are based on the payment profile for sales over the past 12 months as well as the corresponding historical credit losses during that period. The historical rates are then adjusted to reflect current and forwarding-looking factors affecting the customer’s ability to settle the amount outstanding. These factors are determined based on a review of LNG market prices and demand, and regular meetings held with customers which provide insights into their financial position and expected future operational performance. ECLs are recognised in profit or loss within other operating expenses. When a subsequent event causes the amount of impairment charge to decrease, the decrease in impairment charge is reversed through profit or loss.

 

On confirmation that the trade receivable or finance lease receivable will not be collectible, the gross carrying value of the trade receivable or finance lease receivable is written off against the associated allowance and if the associated allowance is not sufficient, the remaining trade receivable or finance lease receivable is written off in profit or loss within other operating expenses.

 

The Group provides 30-day credit terms to debtors and lessees. The Group monitors increases in credit risk associated with trade receivables and lease receivables by regularly reviewing the payment profile of each debtor and taking into account information acquired from regular engagement with customers. Payments by customers after 30 days but before 90 days signify an increase in credit risk; however, customers are not considered to be in default by the Group given the nature of its operations. Trade receivables and lease receivables are considered to be in default when they are 90 days past due, or if any other event has occurred that represents a serious threat to the going concern basis of the debtor.

 

A financial asset is credit impaired when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred, including but not limited to financial difficulty or default of payment. The Group will write off a financial asset when there is no reasonable expectation of recovering it after considering whether all means to recovery the asset have been exhausted, or the counterparty has been liquidated and the Group has assessed that no recovery is possible.

 

Other financial assets at amortised cost (cash and cash equivalents and restricted cash)

 

Impairment allowances for cash and cash equivalents, restricted cash and other receivables are recognised based on a forward-looking ECL model. The methodology used to determine the amount of the allowance is based on whether there has been a significant increase in credit risk since initial recognition of the financial asset. For those where the credit risk has not increased significantly since initial recognition of the financial asset, 12- month ECLs are recognised. For those for which credit risk has increased significantly, lifetime ECLs are recognised. For those that are determined to be credit impaired, lifetime ECLs are recognised.

 

 
14

 

 

The Group deposits cash with banks and financial institutions with high credit standing which are independently rated. An increase in credit risk would be determined with reference to downgrades in these credit ratings.

 

FINANCIAL LIABILITIES

 

Classification

 

The Group classifies its financial liabilities as at amortised cost. At 28 February 2025 and 29 February 2024 the Group did not have financial liabilities at FVTPL or derivative financial instruments.

 

Financial liabilities at amortised cost

 

The Group’s financial liabilities at amortised cost primarily arise from transactions with lenders and suppliers. The Group’s financial liabilities at amortised cost comprise borrowings (note 14) and trade and other payables (note 18).

 

Borrowings

 

Borrowings are initially recognised at fair value net of any transaction costs directly attributable to the issue of the instrument. Such interest-bearing liabilities are subsequently measured at amortised cost using the effective interest rate method, which ensures that any interest expense over the period to repayment is at a constant rate on the balance of the liability carried in the statement of financial position. All interest-related charges are reported in profit or loss within interest expense.

 

Interest-bearing borrowings are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

 

Trade and other payables

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade payables and other short-term monetary liabilities are initially recognised at fair value and subsequently carried at amortised cost using the effective interest method.

 

Derecognition of financial assets and liabilities

 

The Group derecognises a financial asset on trade date when the contractual rights to the cash flows from the asset expire or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another party. The Group derecognises financial liabilities when the Group’s obligations are discharged, cancelled or have expired.

 

On derecognition of a financial asset or financial liability in its entirety, the difference between the carrying amount of the financial asset or financial liability and the sum of the consideration received or receivable/paid or payable is recognised in profit or loss within other operating expenses or other operating income depending on whether a gain or loss is recognised.

 

The recovery of financial assets previously written off is recorded in other operating income in profit or loss.

 

 
15

 

 

1.7 SHARE-BASED PAYMENTS

 

Long-term employee benefits – Bonus Shares

 

The Group operates an equity-settled compensation plan where the Governance, Ethics, Transformation, Social and Compensation Committee (“GETSC”) makes an award of forfeitable shares to the Executive Directors, Prescribed Officers, Senior Management and general employees of the Group. These are referred to as Bonus Shares. This plan has no cash settlement alternatives. The number of Bonus Shares awarded depends on the individual’s annual bonus that has been deferred. The Bonus Shares vest after three years’ service from grant date. This is the only vesting condition pertaining to the Bonus Shares. The terms and conditions of the Bonus Shares, after vesting are the same as those traded publicly.

 

The fair value of the equity-settled instruments is measured by reference to the fair value of the equity instrument granted. Fair value is based on a 30-day volume weighted average (“VWAP”) market price of the equity-settled instrument granted. The grant date fair value of the equity-settled instruments is recognised as an employee benefit expense over the vesting period, with a corresponding increase in the share-based payment reserve.

 

The Bonus Shares grant the holder a right to acquire shares for no consideration.

 

Share options

 

ASX listing

 

As part of the ASX listing, Renergen granted share options to transaction advisers and an Australian Non-executive Director. The fair value was measured at grant date and spread over the period that the option holder was unconditionally entitled to the options, except when the service was completed at grant date in which case the expense was recognised immediately in profit or loss. The fair value of the options granted was measured using the Monte Carlo Method, taking into account the terms and conditions under which the options were granted. The amount recognised as an expense with a corresponding increase in equity was adjusted at each reporting date to reflect the actual number of share options that vest or were expected to vest. Where an option lapses (other than by forfeiture when vesting conditions are not satisfied) it is treated as if it had vested on the date it lapses and any expense not yet recognised for the option is recognised immediately.

 

The vesting of share options awarded to the Non-executive Director occurred annually after each year of completed service (over a four-year period). This was the only vesting condition attributable to these share options. The share options awarded to the Non-executive Director grant him the right to acquire shares at a specific price.

 

The share options awarded to the lead and corporate advisers vested on grant date. The share options awarded to the lead and corporate advisers granted them the right to acquire shares at a specific price.

 

Share Appreciation Rights Plan

 

The Group operates an equity-settled Share Appreciation Rights Plan (“SAR Plan”) where the GETSC makes a once-off award of forfeitable share options to the Executive Directors, Prescribed Officers, Senior Management and general employees of the Group who can influence the growth of the Group. The terms and conditions of the shares issued after vesting and after exercising the share options under the plan, are the same as those traded publicly.

 

The fair value of the share appreciation rights share options granted is measured using the Monte Carlo Method, taking into account the terms and conditions under which the options were granted. The grant date fair value of the share options is recognised as an employee benefit expense over the vesting period, with a corresponding increase in the share-based payment reserve.

 

Share options awarded under the SAR Plan will vest subject to the achievement of performance conditions which are predetermined and linked to the growth of Renergen’s share price, with participants having five years from the award date to achieve any or all performance conditions. For participants to be able to exercise their options, the share price will be required to achieve and sustain the target share price for a 30-day period. Both the vesting and exercise of the share options awarded under the plan are subject to continued employment of a participant.

 

The GETSC reviews the progress on the achievement of performance conditions on a monthly basis throughout the performance period.

 

 
16

 

 

1.8 TAX

 

Current tax assets and liabilities

 

Current tax for current and prior periods is, to the extent unpaid, recognised as a liability.

   

Current tax liabilities/(assets) for the current and prior periods are measured at the amount expected to be paid to/(recovered from) the tax authorities, using the tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

 

Deferred tax assets and liabilities

 

A deferred tax liability is recognised for all taxable temporary differences, except to the extent that the deferred tax liability arises from the initial recognition of an asset or liability in a transaction which, at the time of the transaction, affects neither accounting profit nor taxable profit/(tax loss) and is not part of a business combination or the initial recognition of goodwill.

 

A deferred tax asset is recognised for all deductible temporary differences to the extent that it is probable that taxable profit will be available against which the deductible temporary difference can be utilised. A deferred tax asset is not recognised when it arises from the initial recognition of an asset or liability in a transaction which, at the time of the transaction, affects neither accounting profit nor taxable profit/(tax loss) and is not part of a business combination.

 

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

 

Deductions applicable to oil and gas companies

 

The Tenth Schedule of the South African Income Tax Act permits special tax allowances for companies involved in the exploration of oil and gas. This incentivises companies to pursue oil and gas exploration and creates fiscal certainty for companies involved in oil and gas activities in South Africa. The Tenth Schedule provides a 200%/150% super tax deduction for capital expenditure incurred for exploration and post-exploration respectively, in terms of an oil and gas right, which can be applied against the taxable income of the Group to reduce its tax liability in the year in which the expenditure is incurred. These deductions also affect the tax bases of assets when determining the deferred tax of the Group.

 

Tax expenses

 

Current and deferred taxes are recognised as income or an expense and included in profit or loss for the period.

 

Current tax and deferred taxes are charged or credited to other comprehensive income or loss or equity if they relate to items that are credited or charged, in the same or a different period, to other comprehensive income or loss or equity.

 

1.9 LEASES

 

Group as lessor

 

The Group enters into lease agreements as a lessor whereby customers lease equipment and infrastructure required for the delivery, storage, utilisation and conversion of LNG to natural gas.

 

Leases for which the Group is a lessor are classified as finance or operating leases. Whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee, the contract is classified as a finance lease. All other leases are classified as operating leases.

 

 
17

 

 

Amounts due from lessees under finance leases are recognised as receivables in the statement of financial position at the amount of the Group’s net investment in the leases. At lease commencement date the Group therefore accounts for the finance lease as follows:

 

a) derecognises the carrying amount of the underlying leased asset/identified asset;

 

b) recognises the net investment in the lease; and

 

c) recognises, in profit or loss, any selling profit or loss.

 

The Group determines the lease commencement date to be the date on which it makes an underlying asset available for use by a lessee.

 

Subsequent to initial recognition, finance lease interest is allocated to accounting periods so as to reflect a constant periodic rate of return on the Group’s net investment outstanding in respect of the leases. Finance lease interest is calculated with reference to the gross carrying amount of the lease receivables, except for credit-impaired financial assets for which interest income is calculated with reference to their amortised cost (i.e. after a deduction of the loss allowance). Lease payments are determined in the lease contracts and are applied to reduce the lease receivable by the amounts paid.

 

Impairment considerations applicable to finance lease receivables are dealt with as outlined in note 1.6.

 

When a contract includes both lease and non-lease components, the Group applies IFRS 15 to allocate the consideration under the contract to each component.

 

1.10 PROVISIONS

 

The amount of a provision is the present value of Management’s best estimate of the expenditure expected to be required to settle the obligation. Provisions are not recognised for future operating losses.

 

Environmental Rehabilitation Provision

 

Long-term environmental obligations are based on the Group’s environmental management plans, in compliance with applicable environmental and regulatory requirements. The estimated costs of rehabilitation are reviewed annually and adjusted as appropriate for changes in legislation, technology or other circumstances. Cost estimates are not reduced by the potential proceeds from the sale of assets or from plant clean-up at closure. Changes in estimates are capitalised or reversed against the relevant asset to the extent that it meets the definition of dismantling and removing the item and restoring the site on which it is located. Costs that relate to an existing condition caused by past operations which do not have a future economic benefit are recognised immediately in profit or loss.

 

The Group is required by law to undertake rehabilitation work to address the environmental damage arising from its operations. Part of the cash required to settle the rehabilitation obligation is held in a cash investment account which is restricted (see note 7).

 

1.11 REVENUE FROM CONTRACTS WITH CUSTOMERS

 

The Group derives revenue from contracts with customers as defined in IFRS 15: Revenue from Contracts with Customers from the sale of LNG to two customers.

 

Revenue is recognised at a point in time when the performance obligations have been satisfied, which is once the product is delivered to the destination specified by the customer and the customer has signed for the delivery (proof of delivery).

  

There are no other performance obligations.

 

Revenue is measured at the fair value of the consideration received or receivable, after deducting value-added tax. The consideration received or receivable is allocated to the products based on their selling price per sale agreements and the volumes delivered. Volumes delivered are determined using a metering system. Each delivery is evidenced by a customer weighbridge ticket.

 

 
18

 

 

The Group recognises revenue only when it is probable that the Group will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer and when specific recognition criteria above have been met.

 

The recognition criteria above applies to all sales of LNG. All sales of LNG during the exploration phase are accounted for as revenue. The Group’s customers are afforded 30-day terms for sales of LNG.

 

The Group recognises contract liabilities for consideration received in respect of unsatisfied performance obligations and reports these amounts as other liabilities in its statement of financial position (see note 16).

 

A refund is provided to the customer if the LNG delivered is not in line with the agreed specifications. The Group will be responsible for decanting and refilling the storage tank with the correct specifications. Any claim in this regard must be lodged by the customer in writing within seven days after the date of delivery of the LNG.

 

1.12 COST OF SALES

 

Cost of sales comprise the costs of conversion which are costs directly related to the production of LNG. These costs include utilities, plant depreciation, fuel and lubricants, and employee costs.

 

1.13 TRANSLATION OF FOREIGN CURRENCIES

 

Functional and presentation currency

 

Items included in the consolidated financial statements for each of the Group entities are measured using the functional currency. The consolidated financial statements are presented in South African Rand which is the functional and presentation currency of the Company.

 

Transactions and balances

 

Foreign currency income and expenses are translated into the functional currency using the spot rate on transaction date and assets and liabilities are translated at the closing rate of the relevant month. Gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at closing rates, are recognised in profit or loss, with the exception of exchange differences accounted for as part of borrowing costs as disclosed in note 1.15.

 

Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions.

 

1.14 SEGMENT INFORMATION

 

An operating segment is a component of the Group that engages in business activities which may earn revenues and incur expenses and whose operating results are regularly reviewed by the Group’s chief operating decision-maker (Group Executive Committee) to allocate resources and assess performance, and for which discrete financial information is available. Refer to note 5.

 

The Group’s operating segments and the business activities under each segment are disclosed in note 5.

 

 
19

 

 

Tetra4

 

Tetra4 explores for, produces and sells LNG to the South African market. It also commenced selling LHe subsequent to year-end.

 

Cryovation

 

Cryovation developed the groundbreaking Cryo-VaccTM technology, which enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. The Cryovation business model is undergoing refinement and further development with insights from experts from various fields with the intention of exploring several modifications that will improve the overall concept and operational performance to enhance its appeal for the more niche biologics and gene therapy market internationally. As at 28 February 2025 the Cryo-VaccTM technology remains in development and has not been brought into use.

 

1.15 BORROWING COSTS

 

Specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are capitalised during the period of time that is required to complete and prepare the asset for its intended use. Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use. The LNG and LHe plant is a qualifying asset in terms of IAS 23: Borrowing Costs.

 

Investment income earned on the Debt Service Reserve Account (see note 7), is deducted from the borrowing costs eligible for capitalisation.

 

Other borrowing costs are expensed in the period in which they are incurred.

 

The DFC and IDC loans (and in the prior year also the SBSA and AIRSOL debentures) were obtained specifically for the construction of the VGP. All the borrowing costs that would have otherwise been avoided had the construction not taken place are capitalised.

 

Exchange differences relating to the DFC loan are treated as borrowing costs to the extent that they are an adjustment to interest costs, in accordance with IAS 23: Borrowing Costs paragraph 6(e). This implies that foreign exchange differences are capitalised limited to the difference between the interest on the DFC loan and the interest had the loan been obtained in the functional currency of Tetra4. All other borrowing costs are expensed in profit or loss when they are incurred.

 

The Group presents repayments of interest on borrowings within financing activities in the statement of cash flows.

 

 
20

 

 

2. NEW STANDARDS AND INTERPRETATIONS

 

2.1 STANDARDS AND INTERPRETATIONS EFFECTIVE AND ADOPTED IN THE CURRENT YEAR

 

In the current year the Group has adopted the following standards and interpretations that are effective for the current financial year and that are relevant to its operations.

 

Classification of Liabilities as Current or Non-Current – Amendments to IAS 1

 

The amendments aim to promote consistency in applying the requirements by helping companies determine whether, in the statement of financial position, debt and other liabilities with an uncertain settlement date should be classified as current (due or potentially due to be settled within one year) or non-current.

 

The adoption of these amendments did not have a material impact on the classification of liabilities recorded by the Group.

   

2.2 STANDARDS AND INTERPRETATIONS NOT YET EFFECTIVE

 

Certain new standards, amendments and interpretations to existing standards have been published that are mandatory for the Group’s accounting periods beginning on or after 1 March 2025 or later periods but which the Group has not early adopted. These new standards, amendments and interpretations to existing standards are listed below. The Group is evaluating the impact of these standards, amendments and interpretations and will adopt the applicable standards on 1 March of each year that the standards, amendments and interpretations become effective.

 

Lack of Exchangeability – Amendments to IAS 21: The Effects of Changes in Foreign Exchange Rates (adoption date 1 March 2025)

 

The amendment specifies how an entity should assess whether a currency is exchangeable and how it should determine a spot exchange rate when exchangeability is lacking.

 

Classification and Measurement of Financial Instruments – Amendments to IFRS 9 and IFRS 7 (adoption date 1 March 2026)

 

The amendments address matters identified during the post-implementation review of the classification and measurement requirements of IFRS 9: Financial Instruments. Matters identified include derecognition of financial liabilities, classification of financial assets and disclosures.

 

Annual Improvements to IFRS Accounting Standards (adoption date 1 March 2026)

 

This cycle of annual improvements addresses the following:

 

Hedge Accounting by a First-time Adopter (Amendments to IFRS 1: First-time Adoption of International Financial Reporting Standards);

Disclosure of Deferred Difference between Fair Value and Transaction Price (Amendments to Guidance on implementing IFRS 7);

Gain or Loss on Derecognition (Amendments to IFRS 7);

Introduction and Credit Risk Disclosures (Amendments to Guidance on implementing IFRS 7);

Derecognition of Lease Liabilities (Amendments to IFRS 9);

Transaction Price (Amendments to IFRS 9);

Determination of a “De Facto Agent” (Amendments to IFRS 10); and

Cost Method (Amendments to IAS 7).

 

Presentation and Disclosure in Financial Statements– New accounting standard IFRS 18 (adoption date 1 March 2027)

 

The new standard sets out requirements for the presentation and disclosure of information in the financial statements. The standard will change the disclosure and layout of the Group’s statement of profit or loss, will require improved labelling as well as aggregation and disaggregation of information in the financial statements, and will require the disclosure of management-defined performance measures in the notes to the financial statements.

 

 
21

 

    

3. PROPERTY, PLANT AND EQUIPMENT

   

 

2025

 

 

2024

 

Figures in Rand Thousands 

 

Cost or

valuation

 

 

Accumulated

depreciation

 

 

Net book

value

 

 

Cost or

valuation

 

 

Accumulated

depreciation

 

 

Net book

value

 

Assets under construction

 

 

432594

 

 

 

 

 

 

432594

 

 

 

1284461

 

 

 

 

 

 

1284461

 

Development asset

 

 

321930

 

 

 

(4545 )

 

 

317385

 

 

 

238962

 

 

 

(997 )

 

 

237965

 

Rehabilitation asset

 

 

36909

 

 

 

(1986 )

 

 

34923

 

 

 

 

 

 

 

 

 

 

Right-of-use asset –head office building

 

 

12684

 

 

 

(3305 )

 

9 379

 

 

 

12684

 

 

 

(1101 )

 

 

11583

 

Land – at revalued amount

 

3 600

 

 

 

 

 

3 600

 

 

3 600

 

 

 

 

 

3 600

 

Plant and machinery

 

 

1105820

 

 

 

(61637 )

 

 

1044183

 

 

 

338216

 

 

 

(24446 )

 

 

313770

 

Furniture and fixtures

 

1 582

 

 

 

(1147 )

 

 

435

 

 

1 582

 

 

 

(982 )

 

 

600

 

Motor vehicles

 

 

17124

 

 

 

(7586 )

 

9 538

 

 

 

17224

 

 

 

(4458 )

 

 

12766

 

Office equipment

 

 

287

 

 

 

(193 )

 

 

94

 

 

 

287

 

 

 

(162 )

 

 

125

 

IT equipment

 

1 187

 

 

 

(1132 )

 

 

55

 

 

1 148

 

 

 

(986 )

 

 

162

 

Right-of-use assets – motor vehicles

 

5 671

 

 

 

(4546 )

 

1 125

 

 

5 671

 

 

 

(3475 )

 

2 196

 

Office building

 

 

157594

 

 

 

(10258 )

 

 

147336

 

 

2 065

 

 

 

(888 )

 

1 177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasehold improvements

Office equipment

 

 

 

 

 

 

 

 

 

 

 

142

 

 

 

(142 )

 

 

 

Furniture and fixtures

 

 

12124

 

 

 

(3398 )

 

8 726

 

 

 

10321

 

 

 

(1594 )

 

8 727

 

Total

 

 

2109106

 

 

 

(99733 )

 

 

2009373

 

 

 

1916363

 

 

 

(39231 )

 

 

1877132

 

    

RECONCILIATION OF PROPERTY, PLANT AND EQUIPMENT (“PPE”)

 

 

2025

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Derecognition1

 

 

Transfers2

 

 

Additions

 

 

Depreciation

 

 

At

28 February

2025

 

Assets under construction

 

 

1284461

 

 

 

 

 

 

(960042 )

 

 

108175

 

 

 

 

 

 

432594

 

Development asset3

 

 

237965

 

 

 

 

 

 

82968

 

 

 

 

 

 

(3548 )

 

 

317385

 

Rehabilitation asset

 

 

 

 

 

 

 

 

36909

 

 

 

 

 

 

(1986 )

 

 

34923

 

Right-of-use asset – head office building

 

 

11583

 

 

 

 

 

 

 

 

 

 

 

 

(2204 )

 

9 379

 

Land – at revalued amount

 

3 600

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3 600

 

Plant and machinery

 

 

313770

 

 

 

 

 

 

767604

 

 

 

 

 

 

(37191 )

 

 

1044183

 

Furniture and fixtures

 

 

600

 

 

 

 

 

 

 

 

 

 

 

 

(165 )

 

 

435

 

Motor vehicles

 

 

12766

 

 

 

(100 )

 

 

 

 

 

 

 

 

(3128 )

 

9 538

 

Office equipment

 

 

125

 

 

 

 

 

 

 

 

 

 

 

 

(31 )

 

 

94

 

IT equipment

 

 

162

 

 

 

 

 

 

 

 

 

39

 

 

 

(146 )

 

 

55

 

Right-of-use assets – motor vehicles

 

2 196

 

 

 

 

 

 

 

 

 

 

 

 

(1071 )

 

1 125

 

Office building4

 

1 177

 

 

 

 

 

 

155529

 

 

 

 

 

 

(9370 )

 

 

147336

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasehold improvements

Furniture and fixtures

 

8 727

 

 

 

 

 

 

 

 

1 803

 

 

 

(1804 )

 

8 726

 

Total

 

 

1877132

 

 

 

(100 )

 

 

82968

 

 

 

110017

 

 

 

(60644 )

 

 

2009373

 

 

1.

The Group sold a motor vehicle with a book value of R0.1 million for R0.2 million. The profit on derecognition of R0.1 million is disclosed in note 21.

2.

Plant and machinery and an office building totalling R923.1 million were brought into use during the year, resulting in transfers out of assets under construction to plant and machinery (R767.6 million) and the office building (R155.5 million). A rehabilitation asset totalling R36.9 million was also transferred for assets under construction during the year under review.

3.

Costs amounting to R83.0 million were transferred from exploration and development costs due to the commercial viability of the extraction of LNG being demonstrable (see note 4).

4.

Office building includes the plant office administration building, warehouse and other civil structures for Phase 1.

 

There were no additional costs recognised for environmental rehabilitation in the current year.

 

 
22

 

 

3. PROPERTY, PLANT AND EQUIPMENT continued

 

 

2024

 

Figures in Rand Thousands

 

At

1 March

2023

 

 

Revaluation

 

 

Derecognition1

 

 

Environmental

rehabilitation

costs2

 

 

Transfers3

 

 

Additions

 

 

Depreciation

 

 

At

29 February

2024

 

Assets under construction

 

 

1342450

 

 

 

 

 

 

 

 

 

(3055 )

 

 

(322062 )

 

 

267128

 

 

 

 

 

 

1284461

 

Development asset4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

238962

 

 

 

 

 

 

(997 )

 

 

237965

 

Right-of-use asset – head office building

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12684

 

 

 

(1101 )

 

 

11583

 

Land – at revalued amount

 

3 473

 

 

 

127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3 600

 

Plant and machinery

 

9 660

 

 

 

 

 

 

 

 

 

 

 

 

315052

 

 

 

 

 

 

(10942 )

 

 

313770

 

Furniture and fixtures

 

 

394

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

342

 

 

 

(136 )

 

 

600

 

Motor vehicles

 

8 451

 

 

 

 

 

 

 

 

 

 

 

7 010

 

 

 

 

 

 

(2695 )

 

 

12766

 

Office equipment

 

 

108

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

44

 

 

 

(27 )

 

 

125

 

IT equipment

 

 

376

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(214 )

 

 

162

 

Right-of-use assets – motor vehicles

 

3 115

 

 

 

 

 

 

(915 )

 

 

 

 

 

 

 

 

984

 

 

 

(988 )

 

2 196

 

Office building

 

1 383

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(206 )

 

1 177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasehold improvements

Office equipment

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2 )

 

 

 

Furniture and fixtures

 

2 336

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7 257

 

 

 

(866 )

 

8 727

 

Total

 

 

1371748

 

 

 

127

 

 

 

(915 )

 

 

(3055 )

 

 

238962

 

 

 

288439

 

 

 

(18174 )

 

 

1877132

 

   

1.

The Group derecognised a leased motor vehicle with a book value of R0.9 million which was stolen during the year. The loss on derecognition of this leasing arrangement is reconciled in note 15.

2.

The reversal of rehabilitation costs is outlined in note 17.

3.

Plant and machinery and motor vehicles totalling R322.1 million were brought into use during the year, resulting in transfers out of assets under construction to plant and machinery (R315.1 million) and motor vehicles (R7.0 million).

4.

Costs amounting to R239.0 million were transferred from exploration and development costs due to the commercial viability of the extraction of LNG being demonstrable.

 

Pledge of assets

 

Tetra4 concluded finance agreements with the DFC on 20 August 2019 and the IDC on 17 December 2021 (see note 14). All physical assets are held as security for the debt under these agreements. Physical assets have a carrying amount of R1.6 billion as at 28 February 2025 (2024: prior year security comprised assets under construction and land totalling R1.3 billion), representing 100% (2024: 100%) of each of these asset categories.

 

Additions

 

Additions include foreign exchange differences attributable to the DFC loan and interest capitalised as part of borrowing costs in line with the Group’s policy. These costs and exchange differences were capitalised within assets under construction. In the prior year additions also included non-cash additions to right-of-use assets.

 

The Group’s capitalisation policy for borrowing costs is provided in note 1.15 and borrowings are disclosed in note 14. Borrowing costs amounting to R13.2 million (2024: R107.3 million) were capitalised to assets under construction, representing 19% (2024: 79%) of borrowing costs incurred during the year.

 

 
23

 

 

3. PROPERTY, PLANT AND EQUIPMENT continued

 

A reconciliation of additions to exclude the impact of capitalised borrowing costs (inclusive of foreign exchange differences) and non-cash additions to right-of-use assets is provided below:

 

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Additions as shown above

 

 

 

 

 

110017

 

 

 

288439

 

Capitalised interest attributable to the DFC loan

 

 

28

 

 

 

(13512 )

 

 

(32927 )

Unrealised foreign exchange gains/(losses) attributable to the DFC loan

 

 

28

 

 

 

36704

 

 

 

(16548 )

Capitalised interest attributable to the IDC loan

 

 

28

 

 

 

(9979 )

 

 

(23398 )

Capitalised interest attributable to the SBSA bridge loan

 

 

28

 

 

 

 

 

 

(30798 )

Capitalised interest attributable to the AIRSOL debentures

 

 

28

 

 

 

 

 

 

(3648 )

Net movement in accruals attributable to assets under construction

 

 

18

 

 

 

(17749 )

 

 

54422

 

Non-cash additions to right-of-use assets

 

 

 

 

 

 

 

 

 

(13668 )

Additions as reflected in the cash flow statement

 

 

 

 

 

 

105481

 

 

 

221874

 

   

Capital commitments

 

Capital commitments attributable to assets under construction are disclosed in note 29.

 

Revalued property

 

On 6 February 2024 the Group revalued its land on two farm properties in the Free State by R0.13 million (R0.11 million net of taxation). The properties were revalued to their market value by an independent valuer using the comparable sales method which relied on level 3 inputs as per the IFRS 13 requirements for determining fair value. The comparable sales method assumes that the market value of property should be the average of similar properties that have been sold in the area. The net gain on revaluation was recognised against the revaluation reserve (see note 26.1) during the prior year.

 

The significant unobservable input is the average price per hectare which was R8 810 at 6 February 2024. Significant increases/(decreases) in the estimated price per hectare in isolation would result in a significantly higher/(lower) fair value on a linear basis. A 10% increase/(decrease) in the average price per hectare would result in an increase/(decrease) in the fair value of the land by R0.4 million. The total land size is 408.5897 hectares. Management determined that the effect of changes in fair values between the last valuation date (6 February 2024) and 28 February 2025 was immaterial. This conclusion was reached based on a high-level assessment performed using information obtained from a Windeed search on prices of similar properties in the area.

 

If the land was stated on the historical cost basis, the net book value would be as follows:

 

Figures in Rand Thousands

 

 

2025

 

 

 

2024

 

Cost

 

2 777

 

 

 

2 777

 

Net book value

 

 

2 777

 

 

 

2 777

 

 

Land is not depreciated.

 

Leased assets

 

On 1 September 2023 Renergen concluded an agreement to lease the head office from its landlord under a 5.75-year lease. The lease will terminate on 31 May 2029. The lease is reflected on the statement of financial position as a right-of-use asset and a lease liability. The Group classifies its right-of-use assets in a consistent manner to its property, plant and equipment.

 

The lease generally imposes a restriction that, unless there is a contractual right for the Group to sublet the asset to another party, the right-of-use asset can only be used by the Group. The Group is prohibited from selling or pledging the underlying leased assets as security. The corresponding lease liabilities’ disclosures for the right-of-use assets are provided in note 15.

 

 
24

 

 

4. INTANGIBLE ASSETS

 

 

2025

 

 

2024

 

Figures in Rand Thousands

 

Cost

 

 

Accumulated

amortisation

 

 

Net book

value

 

 

Cost

 

 

Accumulated

amortisation

 

 

Net book

value

 

Acquired intangible assets

 

Exploration and development costs

 

 

 

 

 

 

 

 

 

 

 

56031

 

 

 

(32 )

 

 

55999

 

Computer software

 

9 568

 

 

 

(5820 )

 

3 748

 

 

9 568

 

 

 

(3907 )

 

5 661

 

 

Internally developed intangible assets

Development costs – Cryo-VaccTM

 

 

17070

 

 

 

 

 

 

17070

 

 

 

17070

 

 

 

 

 

 

17070

 

Development costs – Helium Tokens System

 

3 482

 

 

 

 

 

3 482

 

 

3 482

 

 

 

 

 

3 482

 

Total

 

 

30120

 

 

 

(5820 )

 

 

24300

 

 

 

86151

 

 

 

(3939 )

 

 

82212

 

 

RECONCILIATION OF INTANGIBLE ASSETS

 

 

2025

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Additions –

separately

acquired

 

 

Transfers1

 

 

Amortisation

 

 

At

28 February

2025

 

Exploration and development costs

 

 

55999

 

 

 

26969

 

 

 

(82968 )

 

 

 

 

 

 

Computer software

 

5 661

 

 

 

 

 

 

 

 

 

(1913 )

 

3 748

 

Development costs – Cryo-VaccTM

 

 

17070

 

 

 

 

 

 

 

 

 

 

 

 

17070

 

Development costs – Helium Tokens System

 

3 482

 

 

 

 

 

 

 

 

 

 

 

3 482

 

Total

 

 

82212

 

 

 

26969

 

 

 

(82968 )

 

 

(1913 )

 

 

24300

 

 

1.   

Costs amounting to R83.0 million were transferred to property, plant and equipment due to the commercial viability of the extraction of LNG being demonstrable.

 

Figures in Rand Thousands

 

2024

 

 

 

At

1 March

2023

 

 

Additions –

separately

acquired

 

 

Additions –

internally

developed

 

 

Transfers1

 

 

Amortisation

 

 

At

29 February

2024

 

Exploration and development costs

 

 

217427

 

 

 

77534

 

 

 

 

 

 

(238962 )

 

 

 

 

 

55999

 

Computer software

 

5 274

 

 

2 921

 

 

 

 

 

 

 

 

 

(2534 )

 

5 661

 

Development costs – Cryo-VaccTM

 

 

15666

 

 

 

 

 

1 404

 

 

 

 

 

 

 

 

 

17070

 

Development costs – Helium Tokens System

 

3 475

 

 

 

 

 

 

7

 

 

 

 

 

 

 

 

3 482

 

Total

 

 

241842

 

 

 

80455

 

 

1 411

 

 

 

(238962 )

 

 

(2534 )

 

 

82212

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.   

 Costs amounting to R239.0 million were transferred to property, plant and equipment due to the commercial viability of the extraction of LNG being demonstrable.

 

A reconciliation of additions to exclude the impact of accruals is provided below:

 

Figures in Rand Thousands

 

Note

 

 

2025

 

 

2024

 

Additions as shown above

 

 

 

 

 

26969

 

 

 

81866

 

Net movement in accruals

 

 

18

 

 

 

(327 )

 

 

 

Additions as reflected in the cash flow statement

 

 

 

 

 

 

26642

 

 

 

81866

 

 

 
25

 

 

4. INTANGIBLE ASSETS CONTINUED

 

Exploration and development costs

 

These are costs incurred by Tetra4 in exploring for gas and carrying out related development activities pursuant to its exploration and production rights (reference 24/04/07PR) in the Free State Province, South Africa.

 

Exploration and development costs are transferred to PPE (as a development asset) as soon as the commercial viability of the extraction of LNG (or other gas) is demonstrable. Exploration and development costs are not amortised and the depreciation of development assets commences upon transfer to PPE. All exploration and development costs were transferred to PPE during the current financial year and there were no exploration and development cost as at 28 February 2025.

 

Impairment of exploration and development costs – 2024

 

A Reserve and Resource Evaluation Report (“Evaluation Report”) was completed as at 28 February 2023 by Sproule Incorporated (“Sproule”), an independent sub-surface consultancy based in Calgary, Canada (the report was completed and issued in August 2023). The evaluation was both an engineering and an economic update, based on technical and economic data supplied by Tetra4, and has an effective date of 28 February 2023. Material changes to this Evaluation Report compared to the last one completed in 2021 were reservoir category changes; updates to capital expenditure and operating costs, currency exchange rates, and methane and helium prices; and updates to the field development plan. The impairment assessment as at 29 February 2024 was based on the Evaluation Report (as at 28 February 2023) and Management did not obtain an updated Evaluation Report due to the available headroom.

 

The independent Reserve and Resource estimates and associated economics contained in the Evaluation Report were prepared in accordance with SEC rules and guidance as well as generally accepted geoscience and petroleum engineering and evaluation principles. Proved Plus Probable Helium and Methane Reserves (“2P Gas Reserves”) measured at 372.9 billion cubic feet (“BCF”) as at 28 February 2023 (2021: 420.5 BCF) with a net present value of R42.12 billion (2021: R31.0 billion).

 

The net present value above equates to the recoverable amount which was determined using value-in-use calculations where future estimated cash flows attributable to the 2P Gas Reserves were discounted at 10% (2021: 15%). In order to determine whether the Group’s exploration and evaluation assets were impaired as at 29 February 2024 the carrying amount of these assets of R56.0 million was compared to the recoverable amount of R42.12 billion which resulted in no impairment charge being recognised for the year. Management concluded that the impairment assessment was not sensitive to a change in the recoverable amount or other factors due to the significant headroom of R42.06 billion, being the difference between the carrying amount of exploration and evaluation assets of R56.0 million and their recoverable amount of R42.12 billion.

 

The recoverable amount of R42.12 billion was determined from value-in-use calculations based on cash flow projections from formally approved budgets covering a 15-year period from commencement of operations, which takes into account the life of the VGP. The key assumptions used included: (i) estimated future production based on 2P Gas Reserves accordingly probability weighted; (ii) hydrocarbon prices estimated to be reasonable using empirical data, current prices and prices used in making its exploration and development decisions; and (iii) future operating and development costs as estimated by Tetra4 and reviewed for reasonableness by Sproule.

 

Methane prices

 

A methane price of R357/MMbtu which was held constant over the life of the project (2021: R250/MMbtu which was escalated at the South African CPI of 3.2% per annum (as reported in the March 2021 StatsSA Statistical Survey) and was held constant once the initial price had doubled).

 

Helium prices

 

The initial helium price of R5 904/Mcf which was held constant over the life of the project (2021: R3 555/Mcf (US$237/Mcf) was escalated at the average US CPI of 2.4% per annum and was held constant once the initial price had doubled).

 

Discount rate

 

10% (2021: 15%). The discount rate was aligned with that used by other market participants in the USA where the Company intends to complete the Nasdaq IPO, previously prepared in accordance with the Society of Petroleum Engineers (“SPE”), Petroleum Resources Management System (“PRMS”) guidance.

 

Development costs – Cryo-VaccTM

 

These development costs comprise expenditure incurred during the internal development of Cryo-VaccTM vaccine storage units. No amortisation was recognised during the year as the storage units have not yet been brought into use. Development costs include costs that meet the criteria in note 1.4 and are directly attributable to the development of the storage units. At 28 February 2025 the development costs are not impaired based on an assessment performed by Management. No research and development costs were incurred during the year under review (2024: nil).

 

Development costs – Helium Tokens System

 

These development costs comprise expenditure incurred during the internal development of the helium tokens system. Once fully developed, these tokens will be traded and will allow holders to purchase helium from Tetra4. No amortisation was recognised during the year as the tokens system has not yet been brought into use. Development costs include costs that meet the criteria in note 1.4 and are directly attributable to the development of the tokens. At 28 February 2025 any impairment attributed to the helium tokens system would be immaterial (2024: immaterial).

 

 
26

 

 

5. SEGMENTAL ANALYSIS

 

The Group has identified reportable segments that are used by the Group Executive Committee (chief operating decision-maker) to make key operating decisions, allocate resources and assess performance. For management purposes the Group is organised and analysed as follows:

 

a) Corporate Head Office

 

Corporate Head Office is a segment where all investment decisions are made. Renergen is an investment holding company focused on investing in prospective green projects. Green projects entail pursuing knowledge and practices that can lead to more environmentally friendly and ecologically responsible decisions and lifestyles which can help protect the environment and sustain its natural resources for current and future generations.

 

b) Tetra4

 

Tetra4 explores for, produces and sells LNG and, subsequent to year-end, it also commenced selling LHe. It operates in the Gauteng Province, Free State Province and Mpumalanga Province in the town of Evander. Tetra4’s current customer base is in South Africa.

 

c) Cryovation

 

Cryovation developed the ground-breaking Cryo-VaccTM technology, which enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. The Cryovation business model is undergoing refinement and further development with insights from experts from various fields with the intention of exploring several modifications that will improve the overall concept and operational performance to enhance its appeal for the more niche biologics and gene-therapy market internationally.

 

d) Renergen US

 

Renergen US was incorporated on 16 August 2022 and assists with various fundraising and business development activities of the Group in the US market. Renergen US commenced operations in the prior year.

 

With the exception of Renergen US which carries out its operations in the United States of America (“USA”), all of the Group’s segments are in South Africa. Therefore no additional geographical information is provided. For the year under review all sales of the Group were made by Tetra4 to two South African customers (2024: three South African customers).

 

The analysis of reportable segments as at 28 February 2025 is set out below:

 

 

 

 

 

2025

 

Figures in Rand Thousands

 

Notes

 

 

Corporate

Head Office

 

 

Tetra4

 

 

Cryovation

 

 

Renergen

US

 

 

Total

 

 

Eliminations

 

 

Consolidated

 

Revenue

 

 

 

 

 

 

 

 

52113

 

 

 

 

 

 

 

 

 

52113

 

 

 

 

 

 

52113

 

External

 

 

19

 

 

 

 

 

 

52113

 

 

 

 

 

 

 

 

 

52113

 

 

 

 

 

 

52113

 

Depreciation and amortisation

 

 

20,22

 

 

 

(4015 )

 

 

(58542 )

 

 

 

 

 

 

 

 

(62557 )

 

 

 

 

 

(62557 )

Share-based payment expenses

 

 

12

 

 

 

(2398 )

 

 

(717 )

 

 

 

 

 

 

 

 

(3115 )

 

 

 

 

 

(3115 )

Employee costs

 

 

22

 

 

 

(7065 )

 

 

(19813 )

 

 

 

 

 

(7397 )

 

 

(34275 )

 

6 786

 

 

 

(27489 )

Consulting and advisory fees

 

 

22

 

 

 

(9642 )

 

 

(3513 )

 

 

(77 )

 

 

(73 )

 

 

(13305 )

 

 

362

 

 

 

(12943 )

Listing costs

 

 

22

 

 

 

(3184 )

 

 

 

 

 

 

 

 

 

 

 

(3184 )

 

 

 

 

 

(3184 )

Computer and IT expenses

 

 

22

 

 

 

(1006 )

 

 

(5609 )

 

 

 

 

 

 

 

 

(6615 )

 

 

913

 

 

 

(5702 )

Legal and professional fees

 

 

22

 

 

 

(6063 )

 

 

(4026 )

 

 

 

 

 

 

 

 

(10089 )

 

 

77

 

 

 

(10012 )

Audit fees

 

 

22

 

 

 

(1341 )

 

 

(862 )

 

 

(50 )

 

 

 

 

 

(2253 )

 

 

191

 

 

 

(2062 )

Security

 

 

22

 

 

 

 

 

 

(9990 )

 

 

 

 

 

 

 

 

(9990 )

 

 

 

 

 

(9990 )

Selling and distribution expense

 

 

22

 

 

 

 

 

 

(10942 )

 

 

 

 

 

 

 

 

(10942 )

 

 

 

 

 

(10942 )

Repairs and maintenance

 

 

22

 

 

 

(153 )

 

 

(28928 )

 

 

 

 

 

 

 

 

(29081 )

 

 

3

 

 

 

(29078 )

Insurance

 

 

22

 

 

 

 

 

 

(12257 )

 

 

 

 

 

 

 

 

(12257 )

 

 

 

 

 

(12257 )

Management fees charged to Tetra4

 

 

 

 

 

 

32634

 

 

 

 

 

 

 

 

 

 

 

 

32634

 

 

 

(32634 )

 

 

 

Management fees charged by Renergen US

 

 

 

 

 

 

(10950 )

 

 

(22646 )

 

 

 

 

 

 

 

 

(33596 )

 

 

33596

 

 

 

 

Net foreign exchange gains/(losses)

 

 

22

 

 

2 701

 

 

 

(12558 )

 

 

 

 

 

 

 

 

(9857 )

 

 

 

 

 

(9857 )

Interest income

 

 

23

 

 

 

982

 

 

9 802

 

 

 

 

 

 

 

 

 

10784

 

 

 

 

 

 

10784

 

Imputed interest

 

 

24

 

 

 

 

 

 

(6245 )

 

 

 

 

 

 

 

 

(6245 )

 

 

 

 

 

(6245 )

Interest expense

 

 

24

 

 

 

(34804 )

 

 

(40070 )

 

 

 

 

 

 

 

 

(74874 )

 

 

 

 

 

(74874 )

Taxation

 

 

25

 

 

 

11244

 

 

 

39907

 

 

 

 

 

 

 

 

 

51151

 

 

 

 

 

 

51151

 

Loss for the year

 

 

 

 

 

 

(50268 )

 

 

(196508 )

 

 

(220 )

 

 

260

 

 

 

(246736 )

 

 

(192 )

 

 

(246928 )

Total assets

 

 

 

 

 

 

2023518

 

 

 

2280297

 

 

 

16824

 

 

4 405

 

 

 

4325044

 

 

 

(1975870 )

 

 

2349174

 

Total liabilities

 

 

 

 

 

 

(342700 )

 

 

(898888 )

 

 

(5927 )

 

 

(747 )

 

 

(1248262 )

 

 

13697

 

 

 

(1234565 )

 

 
27

 

 

5. SEGMENTAL ANALYSIS CONTINUED

 

 

 

 

 

 

2024

 

Figures in Rand Thousands

 

Notes

 

 

Corporate

Head Office

 

 

Tetra4

 

 

Cryovation

 

 

Renergen

US

 

 

Total

 

 

Eliminations

 

 

Consolidated

 

Revenue

 

 

 

 

 

 

 

 

28952

 

 

 

 

 

 

 

 

 

28952

 

 

 

 

 

 

28952

 

External

 

 

19

 

 

 

 

 

 

28952

 

 

 

 

 

 

 

 

 

28952

 

 

 

 

 

 

28952

 

Depreciation and amortisation

 

 

20,22

 

 

 

(1991 )

 

 

(17978 )

 

 

 

 

 

 

 

 

(19969 )

 

 

 

 

 

(19969 )

Share-based payment expenses

 

 

12

 

 

 

(6275 )

 

 

(1767 )

 

 

(32 )

 

 

 

 

 

(8074 )

 

 

 

 

 

(8074 )

Employee costs

 

 

22

 

 

 

(5188 )

 

 

(18954 )

 

 

(835 )

 

 

(704 )

 

 

(25681 )

 

 

 

 

 

(25681 )

Consulting and

advisory fees

 

 

22

 

 

 

(7692 )

 

 

(3910 )

 

 

(80 )

 

 

(82 )

 

 

(11764 )

 

 

 

 

 

(11764 )

Listing costs

 

 

22

 

 

 

(1979 )

 

 

 

 

 

 

 

 

 

 

 

(1979 )

 

 

 

 

 

(1979 )

Computer and IT expenses

 

 

22

 

 

 

(291 )

 

 

(5118 )

 

 

(1 )

 

 

 

 

 

(5410 )

 

 

 

 

 

(5410 )

Marketing and advertising

 

 

22

 

 

 

(3842 )

 

 

(602 )

 

 

 

 

 

(62 )

 

 

(4506 )

 

 

 

 

 

(4506 )

Legal and professional fees

 

 

22

 

 

 

(1652 )

 

 

(1982 )

 

 

 

 

 

 

 

 

(3634 )

 

 

 

 

 

(3634 )

Audit fees

 

 

22

 

 

 

(1648 )

 

 

(528 )

 

 

(50 )

 

 

 

 

 

(2226 )

 

 

 

 

 

 

(2226 )

Security

 

 

22

 

 

 

 

 

 

(7459 )

 

 

 

 

 

 

 

 

(7459 )

 

 

 

 

 

(7459 )

Selling and distribution expense

 

 

22

 

 

 

 

 

 

(7910 )

 

 

 

 

 

 

 

 

(7910 )

 

 

 

 

 

(7910 )

Repairs and maintenance

 

 

22

 

 

 

 

 

 

(17022 )

 

 

 

 

 

 

 

 

(17022 )

 

 

 

 

 

(17022 )

Net foreign exchange losses

 

 

22

 

 

 

(2998 )

 

 

(11732 )

 

 

 

 

 

 

 

 

(14730 )

 

 

 

 

 

(14730 )

Interest income

 

 

23

 

 

1 817

 

 

9 074

 

 

 

 

 

 

 

 

 

10891

 

 

 

(38 )

 

 

10853

 

Imputed interest

 

 

24

 

 

 

 

 

 

(5495 )

 

 

 

 

 

 

 

 

(5495 )

 

 

 

 

 

(5495 )

Interest expense

 

 

24

 

 

 

(1088 )

 

 

(16202 )

 

 

 

 

 

 

 

 

(17290 )

 

 

38

 

 

 

(17252 )

Taxation

 

 

25

 

 

3 864

 

 

 

33335

 

 

 

 

 

 

 

 

 

37199

 

 

 

 

 

 

37199

 

Loss for the year

 

 

 

 

 

 

(36051 )

 

 

(70997 )

 

 

(1092 )

 

 

(1652 )

 

 

(109792 )

 

 

 

 

 

(109792 )

Total assets

 

 

 

 

 

 

2129216

 

 

 

2374343

 

 

 

16818

 

 

5 117

 

 

 

4525494

 

 

 

(1816367 )

 

 

2709127

 

Total liabilities

 

 

 

 

 

 

(438246 )

 

 

(951143 )

 

 

(5704 )

 

 

(1848 )

 

 

(1396941 )

 

8 917

 

 

 

(1388024 )

 

The disaggregation of revenue by customer for the year ended 28 February 2025 is as follows:

 

Customer A: R51.1 million or 98.1% (2024: R26.3 million or 90.7%);

Customer B: R1.0 million or 1.9% (2024: R2.5 million or 8.6%); and

Customer C: Rnil (2024: R0.2 million or 0.7%).

 

Therefore R52.1 million or 100% (2024: R28.8 million or 99.3%) of the Group’s revenue depended on the sales of LNG to two customers. This revenue is reported under the Tetra4 operating segment.

 

Inter-segment balances are eliminated upon consolidation and are reflected in the “eliminations” column. There are no inter-segment revenues. The nature of the Group’s revenue and its disaggregation are provided in note 19.

 

 
28

 

 

6. DEFERRED TAX

 

 

 

 

2025

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Recognised

in profit

or loss

 

 

At

28 February

2025

 

 

Deferred

tax asset

 

 

Deferred

tax liability

 

Property, plant and equipment

 

 

(305723 )

 

 

(53261 )

 

 

(358984 )

 

 

 

 

 

(358984 )

Intangible assets

 

2 089

 

 

 

(7109 )

 

 

(5020 )

 

 

 

 

 

(5020 )

Lease liabilities

 

 

(117 )

 

 

439

 

 

 

322

 

 

 

322

 

 

 

 

Finance lease receivables

 

 

(3029 )

 

 

(1326 )

 

 

(4355 )

 

 

 

 

 

(4355 )

Provisions

 

 

12989

 

 

 

(94 )

 

 

12895

 

 

 

12895

 

 

 

 

Deferred revenue

 

4 251

 

 

 

(175 )

 

4 076

 

 

4 076

 

 

 

 

S24c allowance (future expenditure)

 

 

(716 )

 

 

 

 

 

(716 )

 

 

 

 

 

(716 )

Unutilised tax losses

 

 

380691

 

 

 

112677

 

 

 

493368

 

 

 

493368

 

 

 

 

Total

 

 

90435

 

 

 

51151

 

 

 

141586

 

 

 

510661

 

 

 

(369075 )

 

 

 

2024

 

Figures in Rand Thousands

 

At

1 March

2023

 

 

Recognised

in profit

or loss

 

 

At

29 February

2024

 

 

Deferred

tax asset

 

 

Deferred

tax liability

 

Property, plant and equipment

 

 

(186700 )

 

 

(119023 )

 

 

(305723 )

 

 

 

 

 

(305723 )

Intangible assets

 

 

(41473 )

 

 

43562

 

 

2 089

 

 

2 089

 

 

 

 

Lease liabilities

 

 

(223 )

 

 

106

 

 

 

(117 )

 

 

 

 

 

(117 )

Finance lease receivables

 

 

(1827 )

 

 

(1202 )

 

 

(3029 )

 

 

 

 

 

(3029 )

Provisions

 

 

12773

 

 

 

216

 

 

 

12989

 

 

 

12989

 

 

 

 

Deferred revenue

 

4 075

 

 

 

176

 

 

4 251

 

 

4 251

 

 

 

 

S24c allowance (future expenditure)

 

 

(716 )

 

 

 

 

 

(716 )

 

 

 

 

 

(716 )

Unutilised tax losses

 

 

267327

 

 

 

113364

 

 

 

380691

 

 

 

380691

 

 

 

 

Total

 

 

53236

 

 

 

37199

 

 

 

90435

 

 

 

400020

 

 

 

(309585 )

 

The losses incurred by the Group are mainly attributable to its subsidiary, Tetra4. Phase 1 of the plant is now operating but has not reached nameplate capacity, and Tetra4 is producing and selling LNG under long-term contracts. Tetra4 also commenced selling LHe in March 2025 following the commissioning of the helium facility during the year under review.

 

As at 28 February 2025 the Group recognised a deferred tax asset attributable to estimated tax losses totalling R1 827.3 million (2024: R1 410.0 million). These tax losses do not expire unless the tax entity concerned ceases to operate for a period longer than a year. The tax losses are available to be off-set against future taxable profits. For tax years ending on or after 31 March 2023 companies with assessed losses will be entitled to set off a maximum of 80% of their assessed losses (subject to a minimum of R1.0 million) against taxable income in a specific year. Tax losses for which no deferred tax asset was recognised as at 28 February 2025 totalled R696.0 million (2024: R529.9 million).

 

A Group net deferred taxation asset of R141.6 million (2024: R90.4 million) has been recognised as it is estimated that future profits will be available against which the assessed losses can be utilised based on the latest financial projections prepared by Management. The key assumption used is the Group reaching nameplate capacity in the next financial year. Once achieved, the Group will move into a profitable, self-sustaining position from the revenue generated from the sale of LNG and LHe that will be produced from future operations, and the leasing of storage and related infrastructure to customers under eight-year contracts which came into effect during the 2023 financial year. Expected future profits (based on forecasts to 2043) underpin the valuation of the exploration and development assets amounting to R42.12 billion (2024: R42.12 billion) (see note 4).

   

 
29

 

 

7. RESTRICTED CASH

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Non-current

 

Environmental rehabilitation cash guarantee

 

 

15086

 

 

8 838

 

Eskom Holdings SOC Limited (“Eskom”) cash guarantee

 

7 993

 

 

8 405

 

 

 

 

23079

 

 

 

17243

 

 

 

 

 

 

 

 

 

 

Current

DFC

 

 

29824

 

 

 

66969

 

IDC

 

 

19673

 

 

 

20331

 

Debt Service Reserve Accounts (“DSRAs”)

 

 

49497

 

 

 

87300

 

Total

 

 

72576

 

 

 

104543

 

 

Environmental rehabilitation cash guarantee

 

The Group has an obligation to manage the negative environmental impact associated with its operational activities in the Free State. In this regard, the Group has recognised a rehabilitation provision of R44.3 million (2024: R40.5 million) as disclosed in note 17. Cash totalling R15.1 million (2024: R8.8 million) is held in a restricted cash deposit account which has been ring-fenced for use towards the settlement of the environmental rehabilitation obligation. Tetra4 does not have access to this account due to restrictions on the use of the funds imposed by a third party. Interest earned on the cash deposit account is reinvested. This restricted cash has been classified as a non-current asset as the rehabilitation programme is not expected to commence in the next 12 months.

 

Eskom cash guarantee

 

The Eskom cash guarantee represents amounts held as security for the due payment of electricity accounts and as an early termination guarantee.

 

DSRAs

 

DFC

 

As part of the terms of the DFC finance agreement (see note 14) Tetra4 is required at any given date to reserve in a US-dollar-denominated bank account the sum of all payments of principal, interest and fees required to be made to the DFC within the next six months. Should Tetra4 default on any payments due and payable, the DFC reserves the right to fund the settlement of amounts due from this bank account. The bank account is restricted and all interest earned accrues to Tetra4. This interest is recorded in interest income on the statement of profit or loss and other comprehensive loss.

 

Refer to note 14 for the event of default relating to the DSRA requirements for the DFC loan.

 

IDC

 

Similar to the terms of the DFC finance agreement, Tetra4 is also required to reserve in a Rand-denominated bank account the sum of all payments of principal, interest and fees required to be made to the IDC within the next six months. Should Tetra4 default on any payments due and payable, the IDC reserves the right to fund the settlement of amounts due from this bank account. The bank account is restricted and all interest earned accrues to Tetra4. This interest is recorded in interest income on the statement of profit or loss and other comprehensive loss.

 

The DSRAs are held as security for the DFC and IDC loans (see note 14). Foreign exchange losses amounting to R2.8 million (2024: R2.3 million foreign exchange gains) were recognised during the year under review with respect to the DFC DSRA.

 

 
30

 

 

8. FINANCE LEASE RECEIVABLES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Finance lease receivables

 

 

43799

 

 

 

48948

 

Total

 

 

43799

 

 

 

48948

 

 

 

 

 

 

 

 

 

 

The classification of the above finance lease receivables between long-term and short-term is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current

 

 

 

 

 

 

 

 

Finance lease receivables

 

 

37683

 

 

 

42979

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

Finance lease receivables

 

6 116

 

 

5 969

 

Total

 

 

43799

 

 

 

48948

 

 

Finance lease arrangements

 

During the 2023 financial year Tetra4 entered into finance leasing arrangements, as a lessor, with two customers for certain equipment and infrastructure required for the delivery, storage, utilisation and conversion of LNG to natural gas. The average term of finance leases entered into is eight years. Generally, these lease contracts provide for the transfer of the ownership of the leased assets to the lessees upon the fulfilment of contract provisions, including but not limited to the settlement of all amounts due to Tetra4 under the lease contracts. Tetra4’s finance lease arrangements do not include variable payments or lease modifications. The average effective interest rate contracted approximates 9.2% per annum.

 

The Directors of the Company estimate the loss allowance on finance lease receivables at the end of the reporting period at an amount equal to lifetime ECLs using the simplified approach as the lessees are also the Group’s only trade debtors (see note 1.6). None of the finance lease receivables at the end of the reporting period are considered to be impaired (2024: nil) given that there are no historical loss events and that the most recent assessment of market conditions (LNG prices and demand factors) and engagement with customers did not indicate any anticipated future events which could impact the settlement of amounts owed. Accordingly, any ECL allowance recognised would not be material.

 

The maturity analysis of finance lease receivables including the undiscounted lease payments to be received is as follows:

    

Figures in Rand Thousands

 

2025

 

 

2024

 

Amounts receivable under finance leases:

 

 

 

 

 

 

Year 1

 

 

10300

 

 

 

11241

 

Year 2

 

 

10300

 

 

 

10376

 

Year 3

 

 

10300

 

 

 

10376

 

Year 4

 

 

10300

 

 

 

10376

 

Year 5

 

 

10300

 

 

 

10376

 

Year 6 onwards

 

7 723

 

 

 

17293

 

Total undiscounted lease payments receivable

 

 

59223

 

 

 

70038

 

Less: unearned interest income

 

 

(15424 )

 

 

(21090 )

Net investment in the lease

 

 

43799

 

 

 

48948

 

 

 

 

 

 

 

 

 

 

Undiscounted lease payments analysed as:

 

 

 

 

 

 

 

 

Recoverable after 12 months

 

 

48923

 

 

 

58797

 

Recoverable within 12 months

 

 

10300

 

 

 

11241

 

 

 

 

59223

 

 

 

70038

 

 

 

 

 

 

 

 

 

 

Net investment in the lease analysed as:

 

 

 

 

 

 

 

 

Recoverable after 12 months

 

 

37683

 

 

 

42979

 

Recoverable within 12 months

 

6 116

 

 

5 969

 

 

 

 

43799

 

 

 

48948

 

 

 
31

 

 

8. FINANCE LEASE RECEIVABLES continued

 

The movements in finance lease receivables were as follows:

 

 

 

2025

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Interest

income

 

Repayments –

capital

 

 

Repayments –

interest

 

 

At

28 February

2025

 

Finance lease receivables

 

 

48948

 

 

5 210

 

 

(5149 )

 

 

(5210 )

 

 

43799

 

Total

 

 

48948

 

 

5 210

 

 

(5149 )

 

 

(5210 )

 

 

43799

 

 

 

 

2024

 

Figures in Rand Thousands

 

At

1 March

2023

 

 

Lease

remeasure-

ment

 

 

Interest

income

 

Repayments –

capital

 

 

Repayments –

interest

 

 

At

29 February

2024

 

Finance lease receivables

 

 

54559

 

 

 

(11 )

 

5 746

 

 

(5600 )

 

 

(5746 )

 

 

48948

 

Total

 

 

54559

 

 

 

(11 )

 

5 746

 

 

(5600 )

 

 

(5746 )

 

 

48948

 

 

  The following table presents the amounts included in profit or loss:   

          

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Loss on remeasurement of finance lease receivables

 

 

22

 

 

 

 

 

 

(11 )

Interest income – finance lease receivables

 

 

23

 

 

5 210

 

 

5 746

 

Total

 

 

 

 

 

5 210

 

 

5 735

 

 

 
32

 

 

9. TRADE AND OTHER RECEIVABLES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Financial instruments

 

Trade receivables1

 

8 438

 

 

1 941

 

 

 

8 438

 

 

1 941

 

 

 

 

 

 

Non-financial instruments

 

Value-added taxation

 

1 904

 

 

 

13759

 

Deposits

 

2 142

 

 

2 523

 

Prepayments2

 

 

13541

 

 

 

14486

 

 

 

 

17587

 

 

 

30768

 

Total trade and other receivables

 

 

26025

 

 

 

32709

 

   

1.

The increase in trade receivables is attributable due to the overall increase in LNG sales during the year which impacted trade receivables that were outstanding at year-end.

2.

Prepayments include advance payments for property damage and business interruption insurance for the LNG plant.

 

Trade receivables are generally on 30-day terms and are not interest-bearing.

 

CATEGORISATION OF TRADE AND OTHER RECEIVABLES

 

Trade and other receivables are categorised as follows in accordance with IFRS 9: Financial Instruments.

 

Figures in Rand Thousands

 

2025

 

 

2024

 

At amortised cost

 

8 438

 

 

1 941

 

Non-financial instruments

 

 

17587

 

 

 

30768

 

Total

 

 

26025

 

 

 

32709

 

 

The Group applies a simplified approach of recognising lifetime ECLs for trade receivables as these items do not have a significant financing component (see note 1.6). None of the trade receivables at the end of the reporting period are considered to be impaired (2024: nil) given that there are no historical loss events and that the most recent engagement with customers did not indicate any anticipated future events which could impact the settlement of amounts owed. Management has also taken into account the short period exposed to credit risk in making the ECL assessment. Trade receivables due as at 28 February 2025 were settled in March 2025.

 

The carrying values of the Group’s trade and other receivables are denominated in the following currencies:

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Euros

 

2 901

 

 

 

 

South African Rands

 

 

23124

 

 

 

32709

 

Total

 

 

26025

 

 

 

32709

 

 

For purposes of the cash flow statement the movement in trade and other receivables comprises:

   

Figures in Rand Thousands

 

2025

 

 

2024

 

Trade and other receivables at the beginning of the year

 

 

32709

 

 

 

31657

 

Effect of creditors with debit balances

 

2 901

 

 

 

(5043 )

Trade and other receivables at the end of the year

 

 

(26025 )

 

 

(32709 )

Movement in trade and other receivables as per the cash flow statement

 

9 585

 

 

 

(6095 )

 

 
33

 

 

10. CASH AND CASH EQUIVALENTS

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Cash and cash equivalents consist of:

 

Cash at banks and on hand

 

 

11152

 

 

 

24711

 

Short-term deposits

 

 

17165

 

 

 

446364

 

Total

 

 

28317

 

 

 

471075

 

   

Cash at banks earns interest at floating rates. Short-term deposits are made for varying periods (less than three months) depending on the immediate cash requirements of the Group, and earn interest at the respective short-term deposit rates. The Group’s cash and cash equivalents are primarily denominated in South African Rands. The amounts denominated in Australian Dollars at 28 February 2025 are immaterial (2024: R0.3 million). The amounts denominated in US Dollars at 28 February 2025 are immaterial (2024: immaterial). The Group banks with financial institutions with a ba2 Moody’s standalone credit rating. 

 

 
34

 

 

11. STATED CAPITAL

 

Figures in Thousands

 

2025

 

 

2024

 

Authorised

 

500 000 000 no par value shares (number)

 

 

500000

 

 

 

500000

 

 

 

 

 

 

 

 

 

 

Reconciliation of number of shares issued

 

 

Balance at 1 March

 

 

147529

 

 

 

144748

 

Issue of shares – ordinary shares issued for cash

 

7 376

 

 

2 580

 

Issue of shares – share incentive scheme, non-cash

 

 

142

 

 

 

201

 

Balance at 28/29 February

 

 

155047

 

 

 

147529

 

 

 

 

 

 

 

 

 

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Reconciliation of stated capital

 

 

Balance at 1 March

 

 

1170059

 

 

 

1134750

 

Issue of shares

 

 

42558

 

 

 

35309

 

Issue of shares – ordinary shares issued for cash

 

 

39316

 

 

 

32581

 

Issue of shares – share incentive scheme, non-cash

 

3 242

 

 

2 728

 

Share issue costs1

 

 

(2315 )

 

 

 

Balance at 28/29 February

 

 

1210302

 

 

 

1170059

 

 

1.

Share issue costs for the year were unpaid as at 28 February 2025.

 

Shares issued for cash comprise:

    

Nature

Date

Number of

shares issued

’000

Issue price

Rand

Value of

shares issued

R’0001

2025

Issue of shares on the Johannesburg Stock Exchange

28 January 2025

7 376

5.33

39 316

Total

 

7 376

 

39 316

 

 

 

 

 

2024

Issue of shares on the Johannesburg Stock Exchange

17 May 2023

545

18.30

10 000

Exercise of options2

Various

2 035

11.10

22 581

Total

 

2 580

 

32 581

  

1.

The value of shares issued is impacted by rounding.

2.

Shares were issued to numerous parties consisting of existing and new domestic and international institutions and investors. Issue price represents the average exercise price of the options exercised during the year.

 

 
35

 

 

12. EQUITY-SETTLED SHARE-BASED PAYMENTS

 

EMPLOYEE BONUS SHARE SCHEME

 

Shares were granted to Executive Directors, Senior Management and general employees of the Group on the dates specified below pursuant to the Bonus Share Scheme approved by shareholders in September 2017. All shares vest after three years of employment with the Group and there are no other vesting conditions. Shares granted to participants which have not yet vested lapse if the Director or employee leaves the Group. Vesting dates for shares issued under the Bonus Share Scheme are as follows:

 

Grant date

 

Vesting date

1 March 2020

 

1 March 2023

1 July 2021

 

1 July 2024

1 March 2022

 

1 March 2025

 

The fair value per share on grant date relates to the 30-day volume weighted average price (“VWAP”) per share on the JSE on the grant date.

 

Reconciliation of shares granted to date:

 

 

 

 

 

 

 

2025

 

 

2024

 

 

 

Number

of shares

granted

’000

 

 

Fair value

per share at

grant date

Rand1

 

 

Value of

shares at

grant date

R’000

 

 

Number

of shares

granted

’000

 

 

Fair value

per share at

grant date

Rand1

 

 

Value of

shares at

grant date

R’000

 

Balance at the beginning of the year

 

 

268

 

 

 

 

 

7 973

 

 

 

470

 

 

 

 

 

 

10701

 

Vested shares for the year

 

 

(141 )

 

 

22.78

 

 

 

(3242 )

 

 

(202 )

 

 

13.55

 

 

 

(2728 )

Executive Directors

 

 

(106 )

 

 

22.78

 

 

 

(2425 )

 

 

(160 )

 

 

13.55

 

 

 

(2161 )

Senior Management

 

 

(11 )

 

 

22.78

 

 

 

(260 )

 

 

(26 )

 

 

13.55

 

 

 

(356 )

General employees

 

 

(24 )

 

 

22.78

 

 

 

(557 )

 

 

(16 )

 

 

13.55

 

 

 

(211 )

Balance at the end of the year2

 

 

127

 

 

 

 

 

 

4 731

 

 

 

268

 

 

 

 

 

 

7 973

 

 

1.

Numbers presented are impacted by rounding.

2.

Forfeitures, awards granted and weighted average exercise price are all nil (2024: nil).

 

 
36

 

 

12. EQUITY-SETTLED SHARE-BASED PAYMENTS continued

 

ASX listing

 

Renergen granted share options to its ASX lead adviser, corporate adviser and Non-executive Director pursuant to the ASX IPO on 6 June 2019.

 

On 6 June 2019, 1.0 million share options with a strike price of AUD0.96 per option were granted to Dr David King, a Non-executive Director. A quarter (250 000) of these share options vested annually after every year of completed service. These share options lapsed on 26 July 2024.

 

On 6 June 2019, 3.4 million share options with a strike price of AUD0.96 per option and 1.7 million share options with a strike price of AUD0.80 per option were granted to the lead and corporate advisers. These share options vested on the grant date.

 

No share options were exercised during the year. In the prior year the ASX lead adviser and corporate adviser exercised 1.2 million share options (at AUD0.96 or an average of R11.83) and 0.8 million share options (at AUD0.80 or an average of R10.03), respectively. These movements are summarised in the table below.

 

Reconciliation of share options granted to date to the ASX lead adviser, corporate adviser and Non-executive Director:

 

 

 

2025

 

 

2024

 

 

 

Number

of share

options

granted

’000

 

 

Fair value

per share

option at

grant date

Rand

 

 

Value of

share

options

R’000

 

 

Weighted

average

exercise

price

Rand1

 

 

Number

of shares

awarded

’000

 

 

Fair value

per share

option at

grant date

Rand

 

 

Value of

shares

R’000

 

 

Weighted

average

exercise

price

Rand1

 

Balance at 1 March

 

1 000

 

 

 

 

 

 

209

 

 

 

12.04

 

 

3 035

 

 

 

 

 

2 829

 

 

 

11.36

 

Exercised during the year2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2035 )

 

 

 

 

 

(2620 )

 

 

11.08

 

ASX lead adviser

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1190 )

 

 

1.03

 

 

 

(1226 )

 

 

11.83

 

Corporate adviser

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(845 )

 

 

1.65

 

 

 

(1394 )

 

 

10.03

 

Lapsed during the year

 

 

(1000 )

 

 

 

 

 

 

(209 )

 

 

12.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-executive Director

 

 

(1000 )

 

 

0.21

 

 

 

(209 )

 

 

12.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance outstanding at 28/29 February

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 000

 

 

 

 

 

 

 

209

 

 

 

12.04

 

Exercisable at 28/29 February

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 000

 

 

 

 

 

 

 

209

 

 

 

12.04

 

 

1.

Exercise prices are denominated in Australian Dollars and have been translated into South African Rand at the prevailing exchange rate at each year-end date or on the date that the share options were exercised.

2.

Refer to note 11 for shares issued for cash during the year.

 

The fair value at grant date of all share options awarded was determined using the Monte Carlo Method.

 

Share options outstanding at the end of the year have the following expiry dates and exercise prices:

 

 

 

 

 

 

 

Exercise price

 

 

Number of share options

 

 

 

Grant date

 

Expiry date

 

2025

Rand1

 

 

2024

Rand1

 

 

2025

’000

 

 

2024

’000

 

Non-executive Director

 

6 June 2019

 

26 July 2024

 

 

 

 

 

12.04

 

 

 

 

 

1 000

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 000

 

 

1.

Exercise prices are denominated in Australian Dollars and have been translated into South African Rand at the prevailing exchange rate at each year-end date.

 

 
37

 

 

12. EQUITY-SETTLED SHARE-BASED PAYMENTS continued

 

Equity-settled Share Appreciation Rights Plan (“SAR Plan”)

 

The share options below were granted pursuant to the SAR Plan approved by shareholders in July 2021 (see note 1.7). Awards will be subject to the fulfilment of both predetermined performance conditions and continued employment. The share options are categorised into tiers, each of which will be linked to separate performance conditions and performance periods as follows:

 

Tier

 

 

Award

price

Rand

 

 

Performance

period

Years

 

 

Share price

performance

condition

which must

be achieved

Rand

 

 

Share price

percentage

growth from

award date1

 

 

Estimated market cap

at achievement of

share price

performance hurdle

Rand2

 

1

 

 

 

37.50

 

 

 

2

 

 

 

75

 

 

 

231 %

 

 

8813105025

 

2

 

 

 

50.00

 

 

 

3

 

 

 

100

 

 

 

341 %

 

 

11750806700

 

3

 

 

 

62.50

 

 

 

4

 

 

 

125

 

 

 

452 %

 

 

14688508375

 

4

 

 

 

75.00

 

 

 

5

 

 

 

150

 

 

 

562 %

 

 

17626210050

 

 

1.

Calculated on a 30-day VWAP as at 31 May 2021 (R22.65).

2.

Calculated as share price which must be achieved multiplied by the number of shares in issue at the time the SAR Plan was adopted (117 508 067 shares).

 

All awards are subject to malus and clawback, meaning unvested awards can be reduced or cancelled (by application of malus) and exercised and settled awards can be recouped (by application of clawback), should a trigger event occur during the holding period. The trigger events include but are not limited to:

 

a material misstatement of the financial results resulting in an adjustment in the audited consolidated accounts of the Company or the audited accounts of any member of the Group;

 

 

the fact that any information used to determine the quantum of an incentive was based on error or inaccurate or misleading information;

 

 

action or conduct of a participant which, in the reasonable opinion of the Board, amounts to serious misconduct or gross negligence; or

 

 

events or behaviour of a participant, or the existence of events attributable to a participant, which led to the censure of the Company or a member of the Group by a regulatory authority or have had a significant detrimental impact on the reputation of the Company.

 

There were no new SAR Plan awards during the year under review. In the prior year 0.9 million additional share options were awarded to Senior Management and general employees, 1.0 million share options lapsed upon termination of employment of participants and 0.9 million share options lapsed upon expiry date for Executive Directors and select Senior Management. On 18 December 2023, 2.2 million share options previously granted to Senior Management and general employees were reissued to more closely align to the Phase 2-scheduled turn-on date.

     

Reconciliation of share options granted to date under the SAR Plan:

 

 

 

2025

 

 

2024

 

 

 

Number

of share

options

granted

’000

 

 

Fair value

per share

option at

grant date

Rand

 

 

Value of

share

options

R’000

 

 

Weighted

average

exercise

price

Rand

 

 

Number

of shares

awarded

’000

 

 

Fair value

per share

option at

grant date

Rand

 

 

Value of

shares

R’000

 

 

Weighted

average

exercise

price

Rand

 

Balance at 1 March

 

9 488

 

 

 

 

 

 

12127

 

 

 

1.02

 

 

 

10554

 

 

 

 

 

 

16231

 

 

 

61.29

 

Granted during the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executives, Senior Management and general employees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

904

 

 

 

 

 

1 892

 

 

 

56.25

 

Tier 1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

226

 

 

 

4.64

 

 

1 050

 

 

 

37.50

 

Tier 2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

226

 

 

 

2.20

 

 

 

498

 

 

 

50.00

 

Tier 3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

226

 

 

 

1.14

 

 

 

258

 

 

 

62.50

 

Tier 4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

226

 

 

 

0.38

 

 

 

86

 

 

 

75.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lapsed during the year

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Executives, Senior Management and general employees

 

 

(1795 )

 

 

 

 

 

 

(3779 )

 

 

51.73

 

 

 

(1970 )

 

 

 

 

 

 

(5996 )

 

 

49.77

 

Tier 1

 

 

(45 )

 

 

4.64

 

 

 

(209 )

 

 

37.50

 

 

 

(1094 )

 

 

4.64

 

 

 

(5074 )

 

 

37.50

 

Tier 2

 

 

(1563 )

 

 

2.20

 

 

 

(3439 )

 

 

50.00

 

 

 

(194 )

 

 

2.20

 

 

 

(427 )

 

 

50.00

 

Tier 3

 

 

(80 )

 

 

1.14

 

 

 

(91 )

 

 

62.50

 

 

 

(309 )

 

 

1.14

 

 

 

(353 )

 

 

62.50

 

Tier 4

 

 

(107 )

 

 

0.38

 

 

 

(40 )

 

 

75.00

 

 

 

(373 )

 

 

0.38

 

 

 

(142 )

 

 

75.00

 

Total shares awarded to date

 

7 693

 

 

 

 

 

 

8 348

 

 

 

 

 

9 488

 

 

 

 

 

 

 

12127

 

 

 

1.02

 

Exercisable at 28/29 February

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
38

 

  

12. EQUITY-SETTLED SHARE-BASED PAYMENTS continued

 

The fair value at grant date of all share options awarded was determined using the Monte Carlo Method. The significant inputs into the model are provided below:

 

 

 

 

 

Tier 1

 

 

Tier 2

 

 

Tier 3

 

 

Tier 4

 

Spot price

 

(Rand)

 

 

30.14

 

 

 

30.14

 

 

 

30.14

 

 

 

30.14

 

Volatility

 

(%)

 

 

52.6

 

 

 

39.5

 

 

 

32.9

 

 

 

26.3

 

Risk-free rate

 

(%)

 

 

5

 

 

 

5

 

 

 

5

 

 

 

5

 

Option life

 

(Years)

 

 

2

 

 

 

3

 

 

 

4

 

 

 

5

 

Strike price

 

(Rand)

 

 

37.50

 

 

 

50.00

 

 

 

62.50

 

 

 

75.00

 

Dividend yield

 

(%)

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

 Share options outstanding at the end of the year have the following expiry dates and exercise prices:

 

 

 

 

 

 

 

 

 

Exercise price

 

 

Number of share options

 

 

Grant date

 

 

Expiry date

 

 

2025

Rand

 

 

2024

Rand

 

 

2025

 ’000

 

 

2024

’000

 

Tier 2

 

17 Dec 2021

 

 

17 Dec 2024

 

 

 

50.00

 

 

 

50.00

 

 

 

 

 

1 350

 

Tier 3

 

17 Dec 2021

 

 

17 Dec 2025

 

 

 

62.50

 

 

 

62.50

 

 

1 836

 

 

1 836

 

Tier 4

 

17 Dec 2021

 

 

17 Dec 2026

 

 

 

75.00

 

 

 

75.00

 

 

2 322

 

 

2 322

 

Tier 2

 

1 Mar 2022 – Feb 2023

 

 

17 Dec 2024

 

 

 

50.00

 

 

 

50.00

 

 

 

 

 

 

150

 

Tier 3

 

1 Mar 2022 – Feb 2023

 

 

17 Dec 2025

 

 

 

62.50

 

 

 

62.50

 

 

 

250

 

 

 

250

 

Tier 4

 

1 Mar 2022 – Feb 2023

 

 

17 Dec 2026

 

 

 

75.00

 

 

 

75.00

 

 

 

400

 

 

 

400

 

Tier 1

 

18 Dec 2023

 

 

17 Dec 2025

 

 

 

37.50

 

 

 

37.50

 

 

 

489

 

 

 

534

 

Tier 2

 

18 Dec 2023

 

 

17 Dec 2026

 

 

 

50.00

 

 

 

50.00

 

 

 

623

 

 

 

686

 

Tier 3

 

18 Dec 2023

 

 

17 Dec 2027

 

 

 

62.50

 

 

 

62.50

 

 

 

819

 

 

 

899

 

Tier 4

 

18 Dec 2023

 

 

17 Dec 2028

 

 

 

75.00

 

 

 

75.00

 

 

 

954

 

 

1 061

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

7 693

 

 

9 488

 

 

RECONCILIATION OF SHARE-BASED PAYMENTS RESERVE

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Balance at the beginning of the year

 

 

26445

 

 

 

21099

 

 

 

 

 

 

 

 

 

 

Bonus share scheme – share-based payments expense for Renergen participants charged to profit or loss1

 

1 456

 

 

 

757

 

Executive Directors

 

1 302

 

 

 

621

 

Senior Management

 

 

134

 

 

 

88

 

General employees

 

 

20

 

 

 

48

 

 

 

 

 

 

 

 

 

 

Bonus share scheme – share-based payments expense for Tetra4 participants1

 

 

450

 

 

1 767

 

Executive Directors

 

 

 

 

1 262

 

Senior Management

 

 

92

 

 

 

47

 

General employees

 

 

358

 

 

 

458

 

 

 

 

 

 

 

 

 

 

SAR Plan1

 

1 209

 

 

5 550

 

Renergen

 

 

943

 

 

4 297

 

Tetra4

 

 

266

 

 

1 221

 

Cryovation

 

 

 

 

 

32

 

 

 

 

 

 

 

 

 

 

Shares which lapsed during the year1

 

 

 

 

 

 

Vested shares issued during the year

 

 

(3242 )

 

 

(2728 )

Balance at the end of the year

 

 

26318

 

 

 

26445

 

 

1.

Total share-based payments expenses amount to R3 115 000 for the year (2024: R8 074 000).

 

 
39

 

   

13.1 SUBSIDIARIES

 

 

 

 

 

 

Country of

 

 

Principal

place of

 

 

% Holding

 

 

Carrying amount in the separate financial statements of the Company

 

Figures in Rand Thousands

 

Notes

 

 

registration

 

 

business

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Tetra4

 

 

 

 

South Africa

 

 

South Africa

 

 

 

94.5 %

 

 

94.5 %

 

 

1944785

 

 

 

1790068

 

Balance at 1 March

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1790068

 

 

 

630006

 

Conversion of loan to equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1412705

 

Disposal of 2.85% interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(285000 )

Purchase of Tetra4 shares1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

154000

 

 

 

 

Equity contribution relating to share-based payments

 

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

717

 

 

1 767

 

Other equity contribution2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30590

 

Cryovation

 

 

 

 

 

South Africa

 

 

South Africa

 

 

 

100 %

 

 

100 %

 

 

12382

 

 

 

12382

 

Balance at 1 March

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12382

 

 

 

12350

 

Equity contribution relating to share-based payments

 

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32

 

Renergen US

 

 

 

 

 

USA

 

 

USA

 

 

 

100 %

 

 

100 %

 

5 000

 

 

5 000

 

Balance at 1 March

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5 000

 

 

 

 

Equity contribution relating to initial investment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5 000

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1962167

 

 

 

1807450

 

 

1.

On 31 August 2024, 21 October 2024 and 29 January 2025 Renergen subscribed a total of 13 216 additional Tetra4 ordinary shares for a total cash consideration of R154.0 million. According to the Subscription and Shareholders’ Agreement between MGE and Tetra4, the shareholding percentage in Tetra4 will remain unchanged until 31 December 2025. As such, Renergen’s ownership interest in Tetra4 remains at 94.5%.

2.

Prior year other equity contribution refers to capitalised interest totalling R15.7 million and expenses recharged to Tetra4 totalling R14.9 million. Previously these transactions were allocated to the Tetra4 loan account. Due to the conversion of the Tetra4 loan to equity the transactions were allocated to the investment account.

 

The other equity contribution attributable to Tetra4 is comprised of the following:

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Interest treated as an equity contribution in Tetra4

 

 

 

 

 

15679

 

Expenses paid on behalf of Tetra43

 

 

 

 

 

14911

 

Total

 

 

 

 

 

30590

 

 

3.

Expenses paid on behalf of Tetra4 mainly comprised employee costs, advisory costs and legal costs.

 

The Company’s interests in subsidiaries are outlined in the table above and the proportion of ownership interest held equals the voting rights held by the Company. A description of the Cryovation, Renergen US and Tetra4 operations is provided in note 5.

 

Renergen has two share schemes under which its shares are granted to Executives, Senior Management and other employees who can influence the growth of the Group – the Bonus Share Scheme implemented in 2017 and the SAR Plan implemented in December 2021 pursuant to approvals obtained from shareholders. This note should be read together with note 12.

 

All entities within the Group are consolidated. There are no unconsolidated structured entities.

 

 
40

 

  

13.2 NON-CONTROLLING INTEREST

 

Tetra4, a 94.5%-owned subsidiary of the Company, has a material NCI. Tetra4 is the only subsidiary of the Company with a NCI.

 

On 27 February 2024 the Company disposed of a 2.85% interest in Tetra4 to Mahlako Gas Energy (“MGE”). The fair value of the consideration received was R285.0 million. On the same day MGE acquired a further 2.65% interest in Tetra4 by subscribing for shares in Tetra4 for R265.0 million (fair value of consideration). The carrying amount of Tetra4’s net assets on 27 February 2024 was R1 399.4 million. The net assets attributable to a 5.5% interest on that date amounted to R77.0 million. Accordingly, the Group recognised an increase in NCI of R77.0 million and an increase in equity attributable to equity holders of Renergen amounting to R473.0 million in that year.

 

On 31 August 2024, 21 October 2024 and 29 January 2025 Renergen subscribed a total of 13 216 additional Tetra4 ordinary shares for a total cash consideration of R154.0 million. According to the Subscription and Shareholders Agreement between MGE and Tetra4, the shareholding percentage in Tetra4 will remain unchanged until 31 December 2025. As such, NCI’s ownership interest in Tetra4 remains at 5.5%, resulting in an increase in NCI.

 

Tetra4’s summarised financial information, before intra-group eliminations, is presented below together with amounts attributable to NCI.

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Summarised statement of profit or loss and other comprehensive loss (100%)

 

Revenue

 

 

52113

 

 

 

28952

 

Costs of sales

 

 

(80173 )

 

 

(18885 )

Gross (loss)/profit

 

 

(28060 )

 

 

10067

 

Other operating income

 

 

227

 

 

9 778

 

Share-based payments expense

 

 

(717 )

 

 

(1767 )

Other operating expenses

 

 

(171352 )

 

 

(109787 )

Operating loss

 

 

(199902 )

 

 

(91709 )

Interest income

 

9 802

 

 

9 074

 

Interest expense and imputed interest

 

 

(46315 )

 

 

(21697 )

Taxation

 

 

39907

 

 

 

33335

 

Loss for the year

 

 

(196508 )

 

 

(70997 )

Other comprehensive income for the year

 

 

 

 

 

110

 

Total comprehensive loss for the year

 

 

(196508 )

 

 

(70887 )

 

 

 

 

 

 

 

 

 

Summarised statement of financial position (100%)

 

 

Non-current assets

 

 

2181907

 

 

 

2064920

 

Current assets

 

 

98390

 

 

 

309423

 

Non-current liabilities

 

 

(113235 )

 

 

(805632 )

Current liabilities

 

 

(785653 )

 

 

(145511 )

 

 

 

 

 

 

 

 

 

Summarised cash flows (100%)

 

 

Cash flows used in operating activities

 

 

(100105 )

 

 

(14560 )

Cash flows used in investing activities

 

 

(99936 )

 

 

(307633 )

Cash flows generated from financing activities

 

 

29249

 

 

 

470219

 

Net (decrease)/increase in cash and cash equivalents

 

 

(170792 )

 

 

148026

 

 

Tetra4 did not declare a dividend during the year under review (2024: Rnil). Tetra4’s operations are included under the Tetra4 segment (see note 5).

 

The comprehensive loss attributed to the NCI is outlined below:

 

 

 

2025

 

 

2024

 

Figures in Rand Thousands

 

NCI in

subsidiary

 

 

Total

comprehensive

loss allocated

 to NCI

 

 

 NCI share of equity contribution

 

 

Accumulated

NCI

 

 

NCI in

subsidiary

 

 

Total

comprehensive

income

 allocated to NCI

 

 

Accumulated

NCI

 

Tetra4

 

 

5.5 %

 

 

10808

 

 

 

(9,329 )

 

 

75977

 

 

 

5.5 %

 

 

(487 )

 

 

77456

 

 

 
41

 

  

14. BORROWINGS

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Held at amortised cost

 

Molopo Energy Limited (“Molopo”)

 

 

53205

 

 

 

46960

 

DFC

 

 

546393

 

 

 

624181

 

IDC

 

 

160590

 

 

 

173437

 

SBSA

 

 

169159

 

 

 

333798

 

AIRSOL

 

 

137595

 

 

 

57753

 

Total

 

 

1066942

 

 

 

1236129

 

 

The classification of the above borrowings between long term and short term is as follows:

 

Non-current

 

Molopo

 

 

53205

 

 

 

46960

 

DFC

 

 

 

 

 

540957

 

IDC

 

 

 

 

 

160742

 

 

 

 

53205

 

 

 

748659

 

 

 

 

 

 

 

 

 

 

Current

 

 

DFC

 

 

546393

 

 

 

83224

 

IDC

 

 

160590

 

 

 

12695

 

SBSA

 

 

169159

 

 

 

333798

 

AIRSOL

 

 

137595

 

 

 

57753

 

 

 

 

1013737

 

 

 

487470

 

Total

 

 

1066942

 

 

 

1236129

 

 

Movements in the Group’s borrowings are analysed in note 28.

 

Molopo

 

Tetra4 entered into a R50.0 million loan agreement with Molopo on 11 April 2014. The loan term was for a period of 10 financial years and six months commencing on 1 July 2014 (repayable on 31 August 2024). During this period the loan was unsecured and is interest free. The loan was discounted on initial recognition and the unwinding of the discount applied on initial recognition was recognised in borrowing costs as imputed interest.

 

As the loan was not repaid on 31 August 2024 it now accrues interest at the prime lending rate plus 2% (13.00% on 28 February 2025). The loan can only be repaid when Tetra4 declares a dividend and utilises a maximum of 36% of the distributable profits in order to pay the dividend. It is not expected that the loan or interest will be repaid in the next 12 months given the unavailability of distributable profits based on Tetra4’s most recent forecasts. As such, the loan is classified as long term. The loan accrued interest amounting to R6.2 million for the year (at an average rate of 13.33%) (2024: R4.0 million (at an average rate of 12.75%)). The Molopo loan outstanding on 28 February 2025 amounted to R53.2 million (2024: R47.0 million).

 

On 14 November 2024 Molopo initiated legal proceedings against Tetra4 in the High Court of South Africa, Gauteng Local Division, Johannesburg, by issuing a summons alleging a breach of contract when Renergen sold the 5.5% stake in Tetra4 to MGE. The claim pertains to a written loan agreement concluded between Molopo, as the lender, and Tetra4, as the borrower, on or about 11 April 2014. As a consequence, Molopo has purported to cancel the loan agreement, which cancellation is disputed by Tetra4 on the basis that the investment by MGE did not constitute a payment by Tetra4 to its parent in the sale. According to the Lead Times Bulletin for the High Court in Gauteng the soonest hearing date is estimated to only take place in four years and nine months, hence the loan continues to be classified as non-current.

 

DFC

 

Tetra4 entered into a US$40.0 million finance agreement with the DFC on 20 August 2019 (“Facility Agreement”). The first drawdown of US$20.0 million took place in September 2019, the second drawdown of US$12.5 million in June 2020 and the final drawdown of US$7.5 million on 28 September 2021. Tetra4 shall repay the loan in equal quarterly instalments of US$1.08 million (R19.9 million using the rate at 28 February 2025) on each payment date which began on 1 August 2022 and will end on 15 August 2031. The loan is secured by a pledge of the Group’s assets under construction, land and the DSRA disclosed in notes 3 and 7.

 

Interest

 

The first drawdown of $20.0 million attracts interest of 2.11% per annum. Interest on the second and final drawdowns is 1.49% and 1.24% per annum, respectively.

 

Interest is payable by Tetra4 to the DFC quarterly on 15 February, 15 May, 15 August and 15 November of each year (repayment dates) for the duration of the loan. Qualifying interest attributable to assets under construction, within PPE, is capitalised in line with the Group policy. Interest incurred during the year totalled US$0.5 million (R9.9 million) (2024: US$0.6 million (R11.7 million)).

 

 
42

 

   

14. BORROWINGS continued

 

Guarantee fee

 

A guarantee fee of 4% per annum is payable by Tetra4 to the DFC on any outstanding loan balance. The guarantee fee is payable quarterly on the repayment dates. Tetra4 incurred guarantee fees totalling US$1.2 million (R22.6 million) during the year under review (2024: US$1.4 million (R26.6 million)).

 

Commitment fee

 

A commitment fee of 0.5% per annum is payable by Tetra4 to the DFC on any undisbursed amounts under the Facility Agreement. Commitment fees were payable quarterly on the repayment dates. Tetra4 did not pay any commitment fees as there were no undrawn amounts during the year under review (2024: Rnil).

 

Facility fee

 

A once-off facility fee of US$0.4 million (R4.8 million) was paid by Tetra4 to the DFC prior to its first drawdown on 26 September 2019.

 

Maintenance fee

 

An annual maintenance fee of US$0.04 million is payable by Tetra4 to the DFC for the duration of the loan term and is payable on 15 November of each year (commenced on 15 November 2020). The maintenance fee covers administrative costs relating to the loan. Tetra4 incurred maintenance fees amounting to US$0.04 million (R0.6 million) during the year under review (2024: US$0.04 million (R0.7 million)).

 

Non-payment of quarterly DFC repayments

 

To preserve cash resources prior to completing the fundraising for Phase 1C, the Company engaged with the DFC and sought their approval beforehand to not remit the quarterly instalment due on 15 February 2025 which would have covered principal, interest and guarantee payments. Furthermore, the Company requested the DFC for exemption from maintaining the required funds in the DSRA. The non-payment of the quarterly repayment, deviation from the DSRA requirements and failure to make required notifications therefore resulted in default events under the terms of the loan agreement. Whilst the DFC was agreeable to the requests made by the Company and subsequently provided a default waiver after the reporting period (see note 35), effectively resolving cross-default issues related to the SBSA and IDC loan, the default event existed as at 28 February 2025. Under IFRS Accounting Standards liabilities must be classified as current if an entity lacks an unconditional right to defer settlement for at least 12 months after the reporting period (see waiver conditions below). As such, both the DFC and IDC loans were classified as current as at 28 February 2025. Other default events on the DFC loan as at 28 February 2025 included the following:

 

 

reporting defaults arising from changes of ownership and changes in material contracts; and

 

the reporting default arising from the Molopo litigation.

 

 

 

 

The conditional waiver provided by the DFC on 9 April 2025 (see note 35) stipulates the following:

 

 

 

 

Settlement of the outstanding quarterly repayment and remediation of the DSRA requirements by 31 May 2025.

 

No action or judgment is taken against Tetra4 with respect to the Molopo litigation.

 

Successful completion of the construction of the VGP within agreed timelines.

 

Sufficient equity contributions by Renergen to Tetra4 within the agreed timelines.

 

Successful verification of the change in ownership.

 

The default on the DFC loan resulted in cross-defaults on the IDC and SBSA loans. As highlighted above, the Company secured waivers from the DFC, effectively resolving cross-default issues related to the SBSA and IDC loan. Like the DFC loan, the IDC loan was classified as current as at 28 February 2025. The SBSA loan, which is due within 12 months, was already classified as current.

 

Debt covenants

 

The following debt covenants apply to the DFC loan:

 

a) Tetra4 is required to maintain at all times (i) a ratio of all interest-bearing debt to EBITDA of not more than 3.0 to 1; (ii) a ratio of current assets to current liabilities of not less than 1 to 1; and (iii) a reserve tail ratio of not less than 25%.

 

b) Tetra4 is required to maintain at all times (i) a ratio of cash flow for the most recently completed four (4) consecutive full fiscal quarters, taken as a single accounting period, to debt service for the most recently completed four (4) consecutive full fiscal quarters, taken as a single accounting period, of not less than 1.30 to 1; and (ii) a ratio of cash flow for the most recently completed four (4) consecutive full fiscal quarters, taken as a single accounting period, to debt service for the next succeeding four (4) consecutive full fiscal quarters of not less than 1.3 to 1.

 

c) Tetra4 is required to ensure that the DSRA (note 7) is funded in the aggregate of all amounts due to the DFC within the next six months.

 

The covenants in (a) and (b) will apply from 15 August 2025. As of 28 February 2025 Tetra4 did not meet covenant (c). On 9 April 2025 the DFC provided a waiver to address this default as set out above. Tetra4, however, believes that it will be able to comply with the covenants throughout the tenure of the loan.

 

“Reserve tail ratio” means, for any calculation date, the quotient obtained by dividing (a) all of the borrower’s remaining proved reserves as of such calculation date by (b) all of the borrower’s proved reserves as of the date of this agreement.

 

 
43

 

  

14. BORROWINGS continued

 

IDC

Tetra4 entered into a R160.7 million loan agreement with the IDC on 17 December 2021. An amount of R158.8 million was drawn down on 22 December 2021 and is repayable in 102 equal monthly payments which commenced in July 2023. The loan terms included a 12-month interest capitalisation and an 18-month capital repayment moratorium. The loan accrues interest at the prime lending rate plus 3.5% (14.5% on 28 February 2025) and is secured by a pledge of Tetra4’s assets under construction, land and the DSRA disclosed in notes 3 and 7. The IDC loan outstanding on 28 February 2025 amounted to R160.6 million (2024: R173.4 million) and interest accrued during the year amounted to R25.5 million (2024: R27.2 million). Qualifying interest attributable to assets under construction, within PPE, is capitalised in line with the policy of the Group.

 

Debt covenants

The following debt covenants apply to the IDC loan.

a) Tetra4 is required to maintain the same financial and reserve tail ratios, and a DSRA as mentioned under the DFC loan.

b) In addition, Tetra4 shall not make any shareholder dividend distribution, repay any shareholders’ loans and/or pay any interest on shareholders’ loans or make any payments whatsoever to its shareholders without the IDC’s prior written consent, if:

 

 

Tetra4 is in breach of any term of the loan agreement; or

 

the making of such payment would result in a breach of any one or more of the financial ratios above.

 

The covenants in (a) will apply from 15 August 2025. Tetra4 was in compliance with the covenant under (b) above for the year and believes that it will be able to comply with the covenants throughout the tenure of the loan. Tetra4 maintains a DSRA with respect to the IDC loan.

 

SBSA

Renergen obtained a R155.0 million secured loan from SBSA on 30 August 2024 (“SBSA Loan”). The first drawdown of R103.3 million occurred on 31 August 2024 and the second drawdown of R51.7 million occurred on 17 October 2024. Proceeds were used to fund the working capital and expansion of the VGP. Part of the proceeds of the SBSA Loan were also used to pay transaction costs attributable to the loan arrangement.

 

The SBSA Loan accrues interest at a rate linked to three-month JIBAR plus a variable margin (JIBAR plus the margin equated to 20.70% on 28 February 2025). Interest is compounded and capitalised to the principal amount owing. The SBSA Loan is repayable on the earlier of the receipt of proceeds from the proposed Renergen Nasdaq IPO or 30 August 2025.

 

The SBSA Loan is secured by a third ranking pledge of Tetra4’s assets and shares held by Renergen in Tetra4. In addition, CRT Investments Proprietary Limited (“CRT”) an associate of Mr Nicholas Mitchell, and MATC Investments Holdings Proprietary Limited (“MATC”) an associate of Mr Stefano Marani, have entered into cession and pledge agreements (“Pledges”) with SBSA, in terms of which CRT and MATC have pledged and ceded as security, which remains in CRT and MATC’s possession unless called, collectively 17 314 575 Renergen ordinary shares (“Pledged Shares”), to and in favour of SBSA. CRT and MATC’s potential liability under the security given in respect of such financial obligation is capped at the lower of the value of the Pledged Shares or R155.0 million.

 

The Molopo litigation and the need to procure the requisite equity injection by 24 January 2025 resulted in events of default with respect to the SBSA loan agreement. SBSA provided a waiver for the Molopo litigation default event but reserves all its rights with respect to the default on the equity injection. To date, no further remedies have been requested by SBSA due to the progress achieved in securing funding for the VGP. The SBSA Loan outstanding on 28 February 2025 amounted to R169.2 million (2024: R333.8 million) and interest accrued during the year amounted to R16.5 million (2024: R30.8 million). In light of the agreed forbearance of the DFC payment for the quarterly instalment for February 2025, a waiver was sought from SBSA and was issued to Tetra4 on 28 February 2025 in respect of the technical cross-default provisions.

 

AIRSOL

Renergen entered into a US$7.0 million unsecured convertible debenture subscription agreement (“Subscription Agreement”) with AIRSOL, an Italian wholly-owned subsidiary of SOL S.p.A, on 30 August 2023 for the subscription by AIRSOL in Renergen debentures in two tranches of US$3.0 million (“Tranche 1”) and US$4.0 million (“Tranche 2”). Tranche 1 proceeds were received on 30 August 2023 and on 18 March 2024 AIRSOL subscribed for Tranche 2 debentures and Renergen received US$4.0 million (R74.6 million). This transaction is linked to the Nasdaq IPO.

 

The debentures initially had a maturity date of 28 February 2025, which has been extended to 31 August 2025, and accrue interest at a rate of 13% per annum, calculated and compounded semi-annually on the outstanding principal amount. Interest is payable on 28 February and 31 August of each year during the term of the debentures.

 

On maturity the debentures can be settled in cash or converted to shares in Renergen at a conversion rate to be determined by dividing the outstanding principal amount by the conversion price. The conversion price has been agreed as follows:

 

 

If the Nasdaq IPO has not been completed before the maturity date of the debentures, the conversion price will be 90% of the 30-day volume weighted average traded price of Renergen shares on the Johannesburg Stock Exchange.

 

If the Nasdaq IPO has occurred before the maturity date of the debentures and the shares to be issued are Renergen shares admitted to trading on the JSE, the conversion price will be 90% of the Rand equivalent of the deemed US$ price per share applicable in the IPO.

 

If the Nasdaq IPO has occurred before the maturity date of the debentures and the shares to be issued are Renergen American Depositary Shares (“ADSs”), the conversion price will be 90% of the Rand equivalent of the US$ issue price per ADS.

 

Debentures outstanding on 28 February 2025 amounted to US$7.5 million (R137.6 million) (2024: US$3.0 million (R57.8 million)) and interest accrued during the year amounted to US$0.9 million (R16.5 million) (2024: US$0.2 million (R3.6 million)).

 

The debentures have been classified as short term as they have a maturity date of 31 August 2025. They do not have an equity component as they are convertible into variable number of shares.

 

 
44

 

   

15. LEASE LIABILITIES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Non-current

 

 

10011

 

 

 

11613

 

Current

 

1 769

 

 

1 815

 

Total

 

 

11780

 

 

 

13428

 

 

 

 

 

 

 

 

 

 

The maturity analysis of lease liabilities is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lease payments

 

 

Due within one year

 

3 086

 

 

3 534

 

Due within two to three years

 

 

11285

 

 

6 902

 

Due within four to five years

 

1 160

 

 

7 668

 

Due over five years

 

 

 

 

 

961

 

 

 

 

15531

 

 

 

19065

 

Finance charges

 

 

(3751 )

 

 

(5637 )

Net present value

 

 

11780

 

 

 

13428

 

 

The lease liabilities relate to the lease of certain motor vehicles and the head office building. The net book value of the right-of-use assets as at 28 February 2025 is R10.5 million (2024: R13.8 million) (see note 3). The lease term for motor vehicles is five years and 5.75 years for the head office building. Details relating to the head office lease are provided in note 3.

 

There were no breaches or defaults on contracts during the current or prior year.

 

The expenses relating to lease payments not included in the measurement of the lease liabilities are as follows:

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Leases of low-value assets

 

 

118

 

 

 

275

 

Total

 

 

118

 

 

 

275

 

 

As at 28 February 2025 the Group was committed to leases of low-value assets and total commitments at that date were R0.1 million (2024: R0.2 million). Payments made during the year relating to low-value leases totalled R0.1 million (2024: R0.3 million).

 

A reconciliation for the related right-of-use assets is provided in note 3 and the interest expense on leases is disclosed in note 24.

 

The movements in lease liabilities are outlined below:

 

 

2025

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Interest

expense

 

Interest

paid

 

 

Lease

payments

 

 

At

28 February

2025

 

Lease liabilities

 

 

13428

 

 

1 918

 

 

(1918 )

 

 

(1648 )

 

 

11780

 

Total

 

 

13428

 

 

1 918

 

 

(1918 )

 

 

(1648 )

 

 

11780

 

 

 

2024

 

Figures in Rand Thousands

 

At

1 March

2023

 

Derecognition

 

 

New

leases

 

 

Interest

expense

 

 

Interest

paid

 

 

Lease

payments

 

 

At

29 February

2024

 

Lease liabilities

 

2 292

 

 

(831 )

 

 

13668

 

 

 

998

 

 

 

(998 )

 

 

(1701 )

 

 

13428

 

Total

 

2 292

 

 

(831 )

 

 

13668

 

 

 

998

 

 

 

(998 )

 

 

(1701 )

 

 

13428

 

 

During the prior year the Group derecognised a leased motor vehicle with a book value of R0.9 million which was stolen. A reconciliation for the loss on derecognition of leasing arrangement is reconciled below:

 

Figures in Rand Thousands

 

Notes

 

 

2024

 

Carrying amount of right-of-use asset derecognised

 

 

3

 

 

 

(915 )

Carrying amount of the lease liability derecognised

 

 

 

 

 

 

831

 

Insurance recovery

 

 

 

 

 

 

10

 

Loss on derecognition of leasing arrangement

 

 

27

 

 

 

(74 )

 

 
45

 

   

16. DEFERRED REVENUE

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Balance at 1 March

 

 

15743

 

 

 

15093

 

Foreign exchange (gains)/losses

 

 

(648 )

 

 

650

 

Balance at 28/29 February

 

 

15095

 

 

 

15743

 

 

Tokens to the value of $0.8 million (R15.0 million at transaction date) (3 556 units at a price of $225 (R4 206) per unit) were issued during the 2023 financial year. The tokens have no expiry date. When a token is redeemed revenue relating to the transaction is recognised at the original value at which the token was issued.

 

For purposes of the cash flow statement, the movement in deferred revenue excludes the foreign exchange (gains)/losses as these exchange differences are unrealised.

 

17. PROVISIONS

 

RECONCILIATION OF PROVISIONS

 

 

2025

 

 

2024

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Unwinding

of discount

 

 

At

28 February

2025

 

 

At

1 March

2023

 

 

Reversals

 

 

Unwinding

of discount

 

 

At

29 February

2024

 

Non-current

 

Environmental rehabilitation

 

 

40452

 

 

3 883

 

 

 

44335

 

 

 

37564

 

 

 

(655 )

 

3 543

 

 

 

40452

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Environmental rehabilitation

 

 

 

 

 

 

 

 

 

 

2 400

 

 

 

(2400 )

 

 

 

 

 

 

Total

 

 

40452

 

 

3 883

 

 

 

44335

 

 

 

39964

 

 

 

(3055 )

 

3 543

 

 

 

40452

 

 

Prior year decreases in expected costs with respect to the rehabilitation provision were recorded against the rehabilitation asset within PPE (see note 3).

 

ENVIRONMENTAL REHABILITATION

 

The Group has production and exploration rights on land in the Free State (South Africa). Exploration is currently ongoing and a provision of R44.3 million (2024: R40.5 million) has been recognised with respect to the rehabilitation of this land. This amount is based on an estimate of the costs to be incurred to address the following:

 

disturbed infrastructure areas;

existing production wells and all exploration wells;

general surface rehabilitation;

monitoring; and

latent/residual environmental risk related to resealing wells.

 

The Group recognises the rehabilitation provision at the present value of estimated future cash flows associated with the rehabilitation, discounted at a pre-tax discount rate that reflects the current market assessments of the time value of money and the risks specific to the liability.

 

Gross cost to rehabilitate

 

The Group estimates that, based on current environmental and regulatory requirements, the total undiscounted rehabilitation cost is approximately R59.5 million (2024: R48.8 million). The discount rate applied in determining the rehabilitation obligation as at 28 February was 10.0% (2024: 9.6%).

 

This note should be read together with notes 3 and 7.

 

 
46

 

   

18. TRADE AND OTHER PAYABLES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Financial instruments

 

Trade payables

 

 

70206

 

 

 

53367

 

Accrued expenses

 

 

22035

 

 

 

19918

 

 

 

 

92241

 

 

 

73285

 

 

 

 

 

 

 

 

 

 

Non-financial instruments

 

 

Accrued leave pay

 

4 172

 

 

3 995

 

Accrued bonuses

 

 

 

 

4 445

 

Other

 

 

 

 

 

547

 

 

 

4 172

 

 

8 987

 

Total

 

 

96413

 

 

 

82272

 

 

 

 

 

 

 

 

 

 

The carrying values of the Group’s trade and other payables are denominated in the following currencies:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US Dollars

 

 

19292

 

 

 

31189

 

Australian Dollars

 

 

349

 

 

 

224

 

Euros

 

2 041

 

 

3 562

 

South African Rands

 

 

74731

 

 

 

47297

 

Total

 

 

96413

 

 

 

82272

 

 

 

 

 

 

 

 

 

 

For purposes of the cash flow statement the movement in trade and other payables comprises:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade and other payables at the beginning of the year

 

 

(82272 )

 

 

(92313 )

Eliminated in the cash flow statement:

 

 

 

 

 

 

 

 

Accruals attributable to

 

 

 

 

 

 

 

 

– share issue costs

 

 

(2315 )

 

2 208

 

– leave pay

 

 

(209 )

 

 

(906 )

– bonuses

 

4 064

 

 

 

 

– audit fees

 

 

(1127 )

 

 

100

 

– Non-executive Directors’ fees

 

 

(918 )

 

 

(474 )

– assets under construction

 

 

(17749 )

 

 

54422

 

– intangible assets

 

 

(327 )

 

 

 

Net foreign exchange losses

 

 

(420 )

 

 

(2962 )

Exchange differences on translation of foreign operations

 

 

318

 

 

 

(74 )

Reclassification between debtors and creditors

 

 

(2901 )

 

5 043

 

Trade and other payables at the end of the year

 

 

96413

 

 

 

82272

 

Movement in trade and other payables as per the cash flow statement

 

 

(7443 )

 

 

47316

 

 

 
47

 

   

19. REVENUE

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Revenue from contracts with customers

 

Sale of LNG

 

 

52113

 

 

 

28952

 

Total

 

 

52113

 

 

 

28952

 

 

All of the Group’s revenue is recognised when products are delivered to the destination specified by the customer and the customer has gained control of the products through their ability to direct the use of and obtain substantially all the benefits from the products.

 

This note should be read together with note 5 which provides details on the concentration of revenue.

 

20. COST OF SALES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Employee costs

 

5 215

 

 

1 701

 

Plant depreciation

 

 

34237

 

 

1 522

 

Fuel and lubricants

 

 

11977

 

 

2 269

 

Plant waste disposal

 

 

 

 

 

78

 

Movement in inventory

 

 

(902 )

 

 

(1631 )

Utilities

 

 

29646

 

 

 

14946

 

Total

 

 

80173

 

 

 

18885

 

 

21. OTHER OPERATING INCOME

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Profit on disposal of property, plant and equipment (note 3)

 

 

120

 

 

 

 

Gain on remeasurement of financial liability (note 28)

 

 

 

 

9 571

 

Other income

 

 

107

 

 

 

207

 

Total

 

 

227

 

 

9 778

 

 

 
48

 

  

22. OTHER OPERATING EXPENSES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Operating expenses by nature

 

Consulting and advisory fees

 

 

12943

 

 

 

11764

 

Listing costs

 

3 184

 

 

1 979

 

Employee costs1

 

 

27489

 

 

 

25681

 

Pension costs – defined contribution plans

 

3 383

 

 

1 031

 

Depreciation and amortisation2

 

 

28320

 

 

 

18447

 

Computer and IT expenses

 

5 702

 

 

5 410

 

Security

 

9 990

 

 

7 459

 

Selling and distribution expense3

 

 

10942

 

 

7 910

 

Net foreign exchange losses

 

9 857

 

 

 

14730

 

Loss on derecognition of leasing arrangement

 

 

 

 

 

74

 

Loss on remeasurement of finance lease receivables

 

 

 

 

 

11

 

Insurance4

 

 

12257

 

 

3 643

 

Travel and accommodation

 

2 292

 

 

2 388

 

Repairs and maintenance5

 

 

29078

 

 

 

17022

 

Office expenses

 

3 047

 

 

4 343

 

Health and safety

 

3 528

 

 

3 848

 

Audit fees

 

2 062

 

 

2 226

 

Legal and professional fees6

 

 

10 012

 

 

3 634

 

Other operating costs

 

7 574

 

 

 

10328

 

Directors’ fees – Non-executive

 

1 571

 

 

2 793

 

Executive Directors’ remuneration7

 

 

13565

 

 

2 147

 

Total

 

 

196796

 

 

 

146868

 

 

1.

Excludes employee costs amounting to R5.2 million (2024: R1.7 million) attributable to the processing of gas sold which are included in cost of sales.

2.

Refer to the depreciation reconciliation provided in note 27.

3.

Increase attributable to increased LNG operations relative to the prior year.

4.

The increase in insurance is due to assets brought into use during the year for which the insurance expense is no longer capitalised.

5.

The increase in repairs and maintenance costs is attributable to an increase in machine uptime and machine hours.

6.

The increase in legal and professional fees is due to advisory fees for the Nasdaq IPO and for litigation matters.

7.

Directors’ fees amounting to R6.7 million (2024: R15.2 million) were capitalised to assets under construction (note 3) during the year under review.

 

 
49

 

   

23. INTEREST INCOME

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Interest income – cash and cash equivalents

 

5 574

 

 

4 210

 

Interest income – finance lease receivables

 

5 210

 

 

5 746

 

Interest income – South African Revenue Service

 

 

 

 

 

897

 

Total

 

 

10784

 

 

 

10853

 

 

 

 

 

 

 

 

 

 

Interest received as presented in the statement of cash flows comprises:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income – cash and cash equivalents

 

5 574

 

 

4 210

 

Interest income – finance lease receivables

 

5 210

 

 

5 746

 

Interest income – South African Revenue Service

 

 

 

 

 

897

 

Interest received per the statement of cash flows

 

 

10784

 

 

 

10853

 

 

24. INTEREST EXPENSE AND IMPUTED INTEREST

   

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Interest – leasing arrangements

 

 

15

 

 

1 918

 

 

 

998

 

Interest – borrowings

 

 

28

 

 

 

74439

 

 

 

15521

 

Imputed interest – rehabilitation provision

 

 

17

 

 

3 883

 

 

3 543

 

Interest – suppliers

 

 

 

 

 

 

869

 

 

2 682

 

Interest – other

 

 

 

 

 

 

10

 

 

 

3

 

Total

 

 

 

 

 

 

81119

 

 

 

22747

 

 

Interest paid as presented in the statement of cash flows comprises:

 

Interest – leasing arrangements

 

1 918

 

 

 

998

 

Interest – suppliers and other

 

 

879

 

 

2 685

 

Interest paid on leasing and other arrangements per the statement of cash flows

 

2 797

 

 

3 683

 

 

 
50

 

  

25. TAXATION

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Major components of the tax income

 

Deferred

 

 

 

 

 

 

Originating and reversing temporary differences

 

 

51151

 

 

 

37199

 

Total

 

 

51151

 

 

 

37199

 

 

 

 

 

 

 

 

 

 

Reconciliation of effective tax rate

 

 

Accounting loss before taxation

 

 

(298079 )

 

 

(146991 )

Tax at the applicable tax rate of 27% (2024: 27%)

 

 

80481

 

 

 

39688

 

Tax effect of:

 

 

 

 

 

 

 

 

Non-deductible expenses

 

 

 

 

 

 

 

 

– Share-based payments

 

 

(841 )

 

 

(2180 )

– Imputed interest expense

 

 

(2735 )

 

 

144

 

– Penalties

 

 

(29 )

 

 

(46 )

– Listing fees

 

 

(530 )

 

 

 

– Legal

 

 

(3196 )

 

 

 

– Bursaries

 

 

 

 

 

(295 )

Current year losses for which no deferred tax asset has been recognised

 

 

(38778 )

 

 

(25544 )

Special oil and gas allowances1

 

 

15731

 

 

 

25303

 

Increase in rehabilitation guarantee

 

1 048

 

 

 

132

 

Other

 

 

 

 

 

(3 )

Total

 

 

51151

 

 

 

37199

 

 

1.

See note 1.8.

 

 
51

 

   

26. OTHER RESERVES

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Revaluation reserve

 

 

702

 

 

 

702

 

Foreign currency translation reserve

 

 

244

 

 

 

(74 )

Balance at the end of the year

 

 

946

 

 

 

628

 

 

26.1 REVALUATION RESERVE

 

Balance at the beginning of the year

 

 

702

 

 

 

598

 

Revaluation during the year

 

 

 

 

 

104

 

Balance at the end of the year

 

 

702

 

 

 

702

 

 

Details pertaining to the revaluation of properties are provided in note 3.

 

26.2 FOREIGN CURRENCY TRANSLATION RESERVE

 

Balance at the beginning of the year

 

 

(74 )

 

 

 

Foreign exchange gains/(losses) arising on translation of foreign operation

 

 

318

 

 

 

(74 )

Balance at the end of the year

 

 

244

 

 

 

(74 )

 

The foreign currency translation reserve is used to recognise foreign exchange differences arising on the translation of the Company’s foreign subsidiary (Renergen US) with a currency other than the presentation currency.

 

 
52

 

   

27. CASH USED IN OPERATIONS

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Loss after taxation

 

 

 

 

 

(246928 )

 

 

(109792 )

 

 

 

 

 

 

 

 

 

 

 

 

Cash adjustments

 

 

 

 

 

 

 

 

 

 

 

Interest income – cash and cash equivalents

 

 

23

 

 

 

(5574 )

 

 

(5107 )

Interest income – finance lease receivables

 

 

23

 

 

 

(5210 )

 

 

(5746 )

Interest expense – suppliers and other

 

 

24

 

 

 

879

 

 

2 685

 

Interest expense – borrowings

 

 

24,28

 

 

 

68194

 

 

 

10026

 

Interest expense – leasing arrangements

 

 

24

 

 

1 918

 

 

 

998

 

Movement in restricted cash

 

 

7

 

 

 

 

 

 

(12556

)

Non-cash adjustments

 

 

 

 

 

 

 

 

 

 

 

 

Taxation

 

 

 

 

 

 

(51151 )

 

 

(37199 )

Imputed interest – borrowings

 

 

24,28

 

 

6 245

 

 

5 495

 

Imputed interest – rehabilitation provision

 

 

17

 

 

3 883

 

 

3 543

 

Depreciation and amortisation1

 

 

 

 

 

 

62557

 

 

 

20708

 

Share-based payments expense

 

 

12

 

 

3 115

 

 

8 074

 

Loss on lease remeasurement

 

 

8

 

 

 

 

 

 

11

 

Profit on disposal of PPE

 

 

21

 

 

 

(120 )

 

 

 

Loss on derecognition of leasing arrangement

 

 

15

 

 

 

 

 

 

74

 

Gain on remeasurement of financial liability

 

 

21

 

 

 

 

 

 

(9571 )

Increase/(reversal) of audit fee accrual

 

 

 

 

 

1 127

 

 

 

(100 )

Increase in Non-executive Directors’ fees accrual

 

 

 

 

 

 

918

 

 

 

474

 

Increase in leave pay accrual

 

 

 

 

 

 

209

 

 

 

906

 

Reversal of bonus accrual

 

 

 

 

 

 

(4064 )

 

 

 

Net foreign exchange losses

 

 

 

 

 

7 198

 

 

 

17482

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in working capital

 

 

 

 

 

 

 

 

 

 

 

 

Inventory

 

 

 

 

 

 

(1125 )

 

 

(1926 )

Finance lease receivables

 

 

8

 

 

5 149

 

 

5 600

 

Trade and other receivables

 

 

9

 

 

9 585

 

 

 

(6095 )

Trade and other payables

 

 

18

 

 

 

(7443 )

 

 

47316

 

Total

 

 

 

 

 

(150638 )

 

 

(64700

)

 

 

 

 

 

 

 

 

 

 

 

 

 

1. A reconciliation of the depreciation and amortisation charges of the Group is provided below.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortisation comprises:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation of PPE

 

 

3

 

 

 

60644

 

 

 

18174

 

Amortisation of intangible assets

 

 

4

 

 

 1 913

 

 

 2 534

 

Depreciation and amortisation as shown above

 

 

 

 

 

 

62557

 

 

 

20708

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortisation is recorded within these line items in the statement of profit or loss and other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

28320

 

 

 

19186

 

Depreciation and amortisation

 

 

22

 

 

 

28320

 

 

 

18447

 

Repairs and maintenance

 

 

22

 

 

 

 

 

 

739

 

Cost of sales

 

 

20

 

 

 

34237

 

 

1 522

 

Depreciation and amortisation as shown above

 

 

 

 

 

 

62557

 

 

 

20708

 

 

 
53

 

  

28. CHANGES IN LIABILITIES ARISING FROM FINANCING ACTIVITIES

 

RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES

 

 

 

2025

 

 

 

Non-cash movements

 

 

Cash movements

 

 

 

Figures in Rand Thousands

 

At

1 March

2024

 

 

Interest1

 

 

Foreign

exchange

gains2

 

 

Additions

 

 

Repayments

– capital3

 

 

Repayments

– interest3

 

 

At

28 February

2025

(note 14)

 

Molopo

 

 

46960

 

 

6 245

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

53205

 

DFC

 

 

624181

 

 

 

33196

 

 

 

(26072 )

 

 

 

 

 

(59464 )

 

 

(25448 )

 

 

546393

 

IDC

 

 

173437

 

 

 

25470

 

 

 

 

 

 

 

 

 

(12847 )

 

 

(25470 )

 

 

160590

 

SBSA

 

 

333798

 

 

 

16491

 

 

 

 

 

 

155000

 

 

 

(303000 )

 

 

(33130 )

 

 

169159

 

AIRSOL

 

 

57753

 

 

 

16528

 

 

 

(3218 )

 

 

74640

 

 

 

 

 

 

(8108 )

 

 

137595

 

Total

 

 

1236129

 

 

 

97930

 

 

 

(29290 )

 

 

229640

 

 

 

(375311 )

 

 

(92156 )

 

 

1066942

 

 

1.

The Group capitalises interest which qualifies as borrowing costs attributable to the construction of qualifying assets. The interest presented above will therefore not correspond to amounts shown within the additions reconciliation for cash flow purposes as shown in note 3. An analysis of the interest expense between interest which was capitalised or expensed is provided below.

2.

Foreign exchange gains reflect the impact of the strengthening of the Rand against the US Dollar. Qualifying foreign exchange gains amounting to R36.7 million were capitalised to assets under construction within PPE (see note 3). Foreign exchange gains presented above therefore will not correspond to amounts shown within the additions reconciliation for cash flow statement purposes as shown in note 3.

3.

Repayments of capital, interest and fees attributable to the DFC loan, IDC loan, SBSA loan and AIRSOL debentures are in line with loan terms (see note 14). The Group shows repayments of interest under financing activities (see note 1.15).

 

 

2024

 

 

 

 

 

 

Non-cash movements

 

 

Cash movements

 

 

 

Figures in Rand Thousands

 

At

1 March

2023

 

 

Remeasure-

ment1

 

 

Interest2

 

 

Foreign

exchange

losses3

 

 

Additions

 

 

Repayments

– capital4

 

 

Repayments

– interest4

 

 

At

29 February

2024

(note 14)

 

Molopo

 

 

51036

 

 

 

(9571 )

 

5 495

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

46960

 

DFC

 

 

678180

 

 

 

 

 

 

38933

 

 

 

27884

 

 

 

 

 

 

(81883 )

 

 

(38933 )

 

 

624181

 

IDC

 

 

181799

 

 

 

 

 

 

27189

 

 

 

 

 

 

 

 

 

(8362 )

 

 

(27189 )

 

 

173437

 

MaxiConcepts Proprietary Limited (“MaxiConcepts”)

 

 

 

 

 

 

 

 

229

 

 

 

 

 

 

15000

 

 

 

(15000 )

 

 

(229 )

 

 

 

SBSA

 

 

 

 

 

 

 

 

30798

 

 

 

 

 

 

303000

 

 

 

 

 

 

 

 

 

333798

 

AIRSOL

 

 

 

 

 

 

 

3 648

 

 

1 781

 

 

 

55972

 

 

 

 

 

 

(3648 )

 

 

57753

 

Total

 

 

911015

 

 

 

(9571 )

 

 

106292

 

 

 

29665

 

 

 

373972

 

 

 

(105245 )

 

 

(69999 )

 

 

1236129

 

 

1.

The remeasurement arose due to a change in the determination of the loan repayment date. The gain on remeasurement of this financial liability was recognised in other income in the statement of profit or loss and other comprehensive loss.

2.

Interest on the Molopo loan is imputed interest representing the unwinding of the discount applied on initial recognition of the loan. The Group capitalises interest which qualifies as borrowing costs attributable to the construction of qualifying assets. The interest presented above will therefore not correspond to amounts shown within the additions reconciliation for cash flow purposes as shown in note 3. An analysis of the interest expense between interest which was capitalised or expensed is provided below.

3.

Foreign exchange losses reflect the impact of the weakening of the Rand against the US Dollar. Qualifying foreign exchange losses amounting to R16.5 million were capitalised to assets under construction within PPE (see note 3). Foreign exchange losses presented above therefore will not correspond to amounts shown within the additions reconciliation for cash flow statement purposes as shown in note 3.

4.

Repayments of capital, interest and fees attributable to the DFC loan, IDC loan, MaxiConcepts loan and AIRSOL debentures are in line with loan terms (see note 14). The Group shows repayments of interest under financing activities (see note 1.15).

 

 
54

 

   

28. CHANGES IN LIABILITIES ARISING FROM FINANCING ACTIVITIES continued

 

 A reconciliation of the interest which has been recognised in the statement of profit or loss and other comprehensive loss is provided below:

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Interest as shown above

 

 

 

 

 

97930

 

 

 

106292

 

DFC interest capitalised within PPE

 

 

3

 

 

 

(13512 )

 

 

(32927 )

IDC interest capitalised within PPE

 

 

3

 

 

 

(9979 )

 

 

(23398 )

SBSA interest capitalised within PPE

 

 

3

 

 

 

 

 

 

(30798 )

AIRSOL interest capitalised within PPE

 

 

3

 

 

 

 

 

 

(3648 )

Interest on borrowings as presented in profit or loss

 

 

24

 

 

 

74439

 

 

 

15521

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest on borrowings which has been recognised in the statement of profit or loss and other comprehensive loss comprises interest on the following borrowings: 

 

 

 

 

 

 

 

 

 

 

 

 

 

Molopo

 

 

 

 

 

6 245

 

 

5 495

 

DFC

 

 

 

 

 

 

19684

 

 

6 006

 

IDC

 

 

 

 

 

 

15491

 

 

3 791

 

SBSA

 

 

 

 

 

 

16491

 

 

 

 

AIRSOL

 

 

 

 

 

 

16528

 

 

 

 

MaxiConcepts

 

 

 

 

 

 

 

 

 

229

 

Interest on borrowings as presented in profit or loss

 

 

24

 

 

 

74439

 

 

 

15521

 

 

29. COMMITMENTS AND CONTINGENT LIABILITIES

 

29.1 CONTINGENT LIABILITIES

 

Management has assessed the likelihood of outflows in respect of the litigations disclosed in the Directors’ Report as remote. Accordingly, there are no contingent liabilities as at 28 February 2025 attributable to any of the Group companies (2024: nil).

 

29.2 COMMITMENTS

 

 

2025

 

 

2024

 

Figures in Rand Thousands

 

Spent

to date

 

 

Contractual

commitments

 

 

Total

approved

 

 

Spent

to date

 

 

Contractual

commitments

 

 

Total

approved

 

Capital equipment, construction and drilling costs

 

 

158931

 

 

 

81957

 

 

 

240888

 

 

 

349175

 

 

 

122451

 

 

 

471626

 

Total

 

 

158931

 

 

 

81957

 

 

 

240888

 

 

 

349175

 

 

 

122451

 

 

 

471626

 

 

The Board approved total project costs amounting to R1.9 billion (2024: R1.7 billion) relating to the construction of the VGP. At 28 February 2025 the Group had contractual commitments totalling R82.0 million (2024: R122.5 million) for the procurement of capital equipment and services. As at the end of the reporting period there were no other material contractual commitments to acquire capital equipment.

 

 
55

 

    

30. RELATED PARTIES

 

RELATIONSHIPS

 

Subsidiaries

 

See note 13.1

 

 

 

Shareholders with significant influence

 

CRT Investments Proprietary Limited

 MATC Investment Holdings Proprietary Limited

 

 

 

Companies controlled by Directors

 

 

 CRT Investments Proprietary Limited

 MATC Investment Holdings Proprietary Limited

 Luhuhi Investments Proprietary Limited

 

There were no transactions or balances with companies controlled by Directors or shareholders with significant influence during the year under review except for as disclosed under the SBSA loan in note 14 (security provided for the DFC borrowings by companies owned by Mr Stefano Marani and Mr Nicholas Mitchell) (2024: Rnil).

 

Key Management personnel include Executive and Non-executive Directors and members of the Executive Committee. Refer to the Directors’ Report for more details. Remuneration of key Management personnel is disclosed in note 31.

 

31. DIRECTORS’ AND PRESCRIBED OFFICER’S EMOLUMENTS

 

 

 

NON-EXECUTIVES

 

 

2025

 

 

2024

 

 

Figures in Rand Thousands

 

Directors’ Board fees

 

 

Committee fees

 

 

Total

 

 

Directors’ Board fees

 

 

Committee fees

 

 

Total

 

Fees paid to Non-executive Directors:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

David King

 

 

779

 

 

 

121

 

 

 

900

 

 

 

859

 

 

 

 

 

 

859

 

Mbali Swana

 

 

289

 

 

 

211

 

 

 

500

 

 

 

319

 

 

 

211

 

 

 

530

 

Luigi Matteucci1

 

 

134

 

 

 

78

 

 

 

212

 

 

 

319

 

 

 

212

 

 

 

531

 

Thembisa Skweyiya2

 

 

18

 

 

 

15

 

 

 

33

 

 

 

319

 

 

 

89

 

 

 

408

 

Dumisa Hlatshwayo

 

 

289

 

 

 

179

 

 

 

468

 

 

 

319

 

 

 

68

 

 

 

387

 

Total

 

1 509

 

 

 

604

 

 

2 113

 

 

2 135

 

 

 

580

 

 

2 715

 

 

1.

Retired on 26 July 2024.

2.

Resigned on 10 April 2024.

 

 

 

EXECUTIVES

 

 

 

2025

 

 

2024

 

Figures in Rand Thousands

 

Total annual guaranteed package

 

 

Total

 

 

Total annual guaranteed package

 

 

Total

 

Remuneration paid to Executive Directors:

 

 

 

 

 

 

 

 

Stefano Marani

 

9 719

 

 

9 719

 

 

7 366

 

 

7 366

 

Brian Harvey

 

4 404

 

 

4 404

 

 

4 155

 

 

4 155

 

Nick Mitchell

 

6 132

 

 

6 132

 

 

5 785

 

 

5 785

 

Total

 

 

20255

 

 

 

20255

 

 

 

17306

 

 

 

17306

 

 

 

 

PRESCRIBED OFFICER

 

 

2025

 

2024

 

Figures in Rand Thousands

 

Package

 

Medical aid

 

 

Pension

 

 

Total annual guaranteed package

 

Package

 

Medical aid

 

 

Pension

 

 

Total annual guaranteed package

 

Remuneration paid to Prescribed Officer:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leonard Eiser

 

2 646

 

 

83

 

 

 

159

 

 

2 888

 

2 521

 

 

75

 

 

 

50

 

 

2 646

 

Total

 

2 646

 

 

83

 

 

 

159

 

 

2 888

 

2 521

 

 

75

 

 

 

50

 

 

2 646

 

 

The Prescribed Officer is a member of the Executive Committee and is part of the Group’s key Management.

 

Post-employment and termination benefits

 

The Group introduced a defined contribution retirement scheme in July 2023 to improve the employee value proposition. Payments made with respect to the pension scheme are provided in note 22.

  

 
56

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

CATEGORIES OF FINANCIAL INSTRUMENTS

 

Categories of financial assets

 

 

 

 

 

 

Amortised cost

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Restricted cash

 

 

7

 

 

 

72576

 

 

 

104543

 

Trade and other receivables

 

 

9

 

 

8 438

 

 

1 941

 

Cash and cash equivalents

 

 

10

 

 

 

28317

 

 

 

471075

 

Total

 

 

 

 

 

 

109331

 

 

 

577559

 

 

The carrying values of the financial assets disclosed above approximate their fair values.

 

Categories of financial liabilities

     

 

 

 

 

 

Amortised cost

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Trade and other payables

 

 

18

 

 

 

92241

 

 

 

73285

 

Borrowings

 

 

14

 

 

 

1066942

 

 

 

1236129

 

Total

 

 

 

 

 

 

1159183

 

 

 

1309414

 

 

The carrying values of the financial liabilities disclosed above approximate their fair values.

 

PRE-TAX GAINS AND LOSSES ON FINANCIAL INSTRUMENTS

 

Gains on financial assets

 

 

 

 

 

 

Amortised cost

 

Figures in Rand Thousands

 

Note

 

 

2025

 

2024

 

Recognised in profit or loss

 

Interest income

 

 

23

 

 

5 574

 

4 210

 

Total

 

 

 

 

 

5 574

 

4 210

 

 

Gains and (losses) on financial liabilities

   

 

 

 

 

 

Amortised cost

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Recognised in profit or loss

 

Net foreign exchange losses

 

 

22

 

 

 

(9857 )

 

 

(14730 )

Interest – borrowings

 

 

24

 

 

 

(74439 )

 

 

(15521 )

Interest – suppliers and other

 

 

24

 

 

 

(879 )

 

 

(2685 )

Total

 

 

 

 

 

 

(85175 )

 

 

(32936 )

 

 
57

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT continued

 

CAPITAL RISK MANAGEMENT

 

The Group’s objective when managing capital is to safeguard its ability to continue as a going concern in order to provide returns for shareholders and benefits for all other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital. The Group manages its capital structure and makes adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. The Group is targeting a long-term capital structure of a maximum of 34% equity funding and 66% debt funding, taking into consideration the development of Phase 2. Given the amortisation profile of our material debt, this ratio will reduce over time.

 

The Group’s borrowings and equity are disclosed in notes 14 and 11, respectively. Debt covenants relating to loans are disclosed in note 14.

 

Figures in Rand Thousands

 

Notes

 

 

2025

 

 

2024

 

Stated capital

 

 

11

 

 

 

1210302

 

 

 

1170059

 

Borrowings

 

 

14

 

 

 

1066942

 

 

 

1236129

 

Total

 

 

 

 

 

 

2277244

 

 

 

2406188

 

 

The Group’s capital structure as at 28/29 February of each year was as follows:

 

Equity

 

 

53 %

 

 

49 %

Debt

 

 

47 %

 

 

51 %

 

 
58

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT continued

 

FINANCIAL RISK MANAGEMENT

 

Overview

 

The Group is exposed to a variety of financial risks: market risk (including price risk, currency risk, fair value interest rate risk and cash flow interest rate risk), credit risk and liquidity risk. Overall responsibility for the establishment and oversight of the risk management framework rests with the Board of Directors (“Board”). The Board, through the Group Executive Committee, is responsible for the development, monitoring and communication of the processes for managing risk across the Group. The Group’s overall risk management programme ensures that business risks are systematically identified, assessed and reduced to acceptable levels, whether they are insurable or not, without unduly affecting the Group’s competitiveness and flexibility. The Group maintains an integrated, enterprise-wide risk management programme and risks are monitored, measured, assessed and reported to the Board on a quarterly basis. Through this process the Board reviews the effectiveness of the processes put in place and the appropriateness of the objectives and policies it sets to manage financial risks.

 

There have been no substantive changes in the Group’s exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous periods unless otherwise stated in this note.

 

Credit risk

 

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Group is mainly exposed to credit risk from credit sales and cash held on its behalf by counterparties. Credit risk in this regard is managed on a Group basis as well as on an individual company basis to ensure that counterparty default risk is reduced to an acceptable level. Financial assets exposed to credit risk include restricted cash (note 7), cash and cash equivalents (note 10), trade and other receivables (note 9) and finance lease receivables (note 8).

 

Cash and cash equivalents and restricted cash

 

The Group only deposits cash with major banks with high-quality credit standing and limits exposure to any one counterparty. The Group’s cash is held with financial institutions with a ba2 Moody’s credit rating.

 

Trade receivables and lease receivables

 

The Group has established a credit policy under which each new customer is analysed individually for creditworthiness before the Group’s standard payment and delivery terms and conditions are offered. These procedures include third-party credit checks which assist to assess the short-term liquidity and financial position of each prospective customer. Credit limits are also established for each customer which represent the maximum open amount without requiring approval from the Group Executive Committee.

 

The maximum credit risk exposure of the Group is the carrying values of trade and other receivables, restricted cash, cash and cash equivalents and the finance lease receivables disclosed in notes 9, 7, 10 and 8, respectively. These financial assets and related carrying values are listed below.

 

Figures in Rand Thousands

 

 

 

2025

 

 

 

Notes

 

 

Gross carrying amount

 

 

Credit loss  allowance

 

 

Amortised cost

 

 

Leases

 

Finance lease receivables

 

 

8

 

 

 

43799

 

 

 

 

 

 

 

 

 

43799

 

Trade and other receivables

 

 

9

 

 

8 438

 

 

 

 

 

8 438

 

 

 

 

Restricted cash

 

 

7

 

 

 

72576

 

 

 

 

 

 

72576

 

 

 

 

Cash and cash equivalents

 

 

10

 

 

 

28317

 

 

 

 

 

 

28317

 

 

 

 

Total

 

 

 

 

 

 

153130

 

 

 

 

 

 

109331

 

 

 

43799

 

 

Figures in Rand Thousands

 

 

 

2024

 

 

 

Notes

 

 

Gross carrying amount

 

 

Credit loss allowance

 

 

Amortised cost

 

 

Leases

 

Finance lease receivables

 

 

8

 

 

 

48948

 

 

 

 

 

 

 

 

 

48948

 

Trade and other receivables

 

 

9

 

 

1 941

 

 

 

 

 

1 941

 

 

 

 

Restricted cash

 

 

7

 

 

 

104543

 

 

 

 

 

 

104543

 

 

 

 

Cash and cash equivalents

 

 

10

 

 

 

471075

 

 

 

 

 

 

471075

 

 

 

 

Total

 

 

 

 

 

 

626507

 

 

 

 

 

 

577559

 

 

 

48948

 

                

At 28 February 2025 the Group’s exposure to credit risk is not material for reasons highlighted above (also see notes 8 and 9) (2024: Rnil).   

 

 
59

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT continued

 

FINANCIAL RISK MANAGEMENT continued

 

Liquidity risk

 

Liquidity risk arises from the Group’s management of working capital, commitments, and the finance charges and principal repayments on its debt instruments. It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. The Group’s policy is to ensure that it will always have sufficient cash to allow it to meet its liabilities when they become due. Management manages cash flows on a Group basis through an ongoing review of future commitments against available cash and credit facilities. Rolling cash flow forecasts are prepared monthly and spending is monitored for compliance with internal targets. The Group also seeks to reduce liquidity risk by fixing interest rates (and hence cash flows) on a portion of its long-term borrowings; this is further discussed in the “interest rate risk” section below.

 

An event of default was triggered when Tetra4 did not pay the required quarterly instalment for February 2025 with regards to the DFC loan. Furthermore, Renergen defaulted on the provisions of the SBSA loan agreement with respect to the requirement to procure the requisite equity injection by 24 January 2025. Refer to note 14 for further details regarding these events. The assumptions and judgements which impact the Group’s ability to settle or meet its obligations in the normal course of business within the timelines outlined below are provided in note 36.

 

The following table sets out the contractual maturities (representing undiscounted contractual cash flows) of financial liabilities:

 

 

 

 

 

2025

 

Figures in Rand Thousands

 

 

Notes

 

 

Within 3

 months

 

 

Within

4 – 6

months

 

 

Within

7 – 12

months

 

 

1 to 3

years

 

 

3 to 5

years

 

 

Over 5

 years

 

 

Total

 

 

Carrying

amount

 

Non-current liabilities

 

Borrowings

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

86779

 

 

 

 

 

 

86779

 

 

 

53205

 

Lease liabilities

 

 

15

 

 

 

 

 

 

 

 

 

 

 

7 595

 

 

4 586

 

 

 

 

 

 

12180

 

 

9 848

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Borrowings

 

 

14

 

 

 

876142

 

 

 

146155

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1022297

 

 

 

1013737

 

Trade and other payables

 

 

18

 

 

 

92241

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

92241

 

 

 

92241

 

Lease liabilities

 

 

15

 

 

 

813

 

 

 

813

 

 

1 724

 

 

 

 

 

 

 

 

 

 

 

3 351

 

 

1 932

 

Total

 

 

 

 

 

 

969196

 

 

 

146968

 

 

1 724

 

 

7 595

 

 

 

91365

 

 

 

 

 

 

1216848

 

 

 

1170963

 

 

 

 

 

 

2024

 

Figures in Rand Thousands

 

 

Notes

 

 

Within 3  months

 

 

Within

4 – 6

months

 

 

Within

7 – 12

months

 

 

1 to 3

years

 

 

3 to 5

years

 

 

Over 5

 years

 

 

Total

 

 

Carrying

amount

 

Non-current liabilities

 

Borrowings

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

260098

 

 

 

332424

 

 

 

370006

 

 

 

962528

 

 

 

748659

 

Lease liabilities

 

 

15

 

 

 

 

 

 

 

 

 

 

 

6 902

 

 

7 668

 

 

 

961

 

 

 

15531

 

 

 

11613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Borrowings

 

 

14

 

 

 

373191

 

 

 

40917

 

 

 

137540

 

 

 

 

 

 

 

 

 

 

 

 

551648

 

 

 

487470

 

Trade and other payables

 

 

18

 

 

 

73285

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

73285

 

 

 

73285

 

Lease liabilities

 

 

15

 

 

 

884

 

 

 

884

 

 

1 766

 

 

 

 

 

 

 

 

 

 

 

3 534

 

 

1 815

 

Total

 

 

 

 

 

 

447360

 

 

 

41801

 

 

 

139306

 

 

 

267000

 

 

 

340092

 

 

 

370967

 

 

 

1606526

 

 

 

1322842

 

 

 
60

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT continued

 

FINANCIAL RISK MANAGEMENT continued

 

Market risk

 

Market risk arises from the Group’s use of interest-bearing and foreign currency financial instruments. It is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in interest rates (interest rate risk), foreign exchange rates (currency risk) or other market factors (other price risk). The Group’s financial assets and liabilities affected by market risk include trade and other receivables (note 9), cash and cash equivalents (note 10), restricted cash (note 7), deferred revenue (note 16), trade and other payables (note 18) and borrowings (note 14).

 

Foreign currency risk

 

The Group’s operations expose it to foreign currency risk arising from purchases of goods and services, the acquisition of debt and cash held in currencies other than the South African Rand. Foreign exchange risk arises from future commercial transactions and recognised assets and liabilities. During the year under review the Group transacted in currencies including the US Dollar, Australian Dollar and Euro, however the Group is mostly exposed to transactions and balances denominated in US Dollars (see table below). The Group reviews foreign currency exposure, including exposures arising from commitments on a monthly basis. The Group will in future rely on its ability to generate revenue in US Dollars (from Phase 2 of the VGP) which will be utilised to repay debt and other obligations denominated in this currency. In addition, the Group is also exploring foreign currency hedging strategies following the commissioning of Phase 1 of the VGP.

 

Included in the statement of financial position are the following carrying values denominated in currencies other than the Rand:

 

 

 

 

2025

 

Figures in Rand Thousands

 

Notes

 

 

USD

 

 

AUD

 

 

Euro

 

 

Total

 

Restricted cash

 

 

7

 

 

 

29824

 

 

 

 

 

 

 

 

 

29824

 

Trade and other receivables

 

 

9

 

 

 

 

 

 

 

 

2 901

 

 

2 901

 

Cash and cash equivalents

 

 

10

 

 

 

4

 

 

 

10

 

 

 

 

 

 

14

 

Trade and other payables

 

 

18

 

 

 

(19292 )

 

 

(349 )

 

 

(2041 )

 

 

(21682 )

Deferred revenue

 

 

16

 

 

 

(15095 )

 

 

 

 

 

 

 

 

(15095 )

Borrowings

 

 

14

 

 

 

(683988 )

 

 

 

 

 

 

 

 

(683988 )

Total

 

 

 

 

 

 

(688547 )

 

 

(339 )

 

 

860

 

 

 

(688026 )

 

 

 

 

2024

 

Figures in Rand Thousands

 

Notes

 

 

USD

 

 

AUD

 

 

Euro

 

 

Total

 

Restricted cash

 

 

7

 

 

 

66969

 

 

 

 

 

 

 

 

 

66969

 

Cash and cash equivalents

 

 

10

 

 

 

4

 

 

 

333

 

 

 

 

 

 

337

 

Trade and other payables

 

 

18

 

 

 

(31189 )

 

 

(224 )

 

 

(3562 )

 

 

(34975 )

Deferred revenue

 

 

16

 

 

 

(15743 )

 

 

 

 

 

 

 

 

(15743 )

Borrowings

 

 

14

 

 

 

(681934 )

 

 

 

 

 

 

 

 

(681934 )

Total

 

 

 

 

 

 

(661893 )

 

 

109

 

 

 

(3562 )

 

 

(665346 )

 

 
61

 

 

32. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT continued

 

FINANCIAL RISK MANAGEMENT continued

 

A variation in the exchange rate, with all other variables held constant, would impact the Group’s post-tax loss and equity as follows:

 

Figures in Rand Thousands

 

2025

 

 

2024

 

Weakening of the Rand against the US Dollar by 5%

 

 

(34427 )

 

 

(33095 )

Strengthening of the Rand against the US Dollar by 5%

 

 

34427

 

 

 

33095

 

 

Balances denominated in Australian Dollar and Euros are not material and therefore a sensitivity analysis is not provided.   

 

Figures in Rand

 

2025

 

 

2024

 

Year-end exchange rates

 

US Dollar

 

 

18.4536

 

 

 

19.2456

 

Australian Dollar

 

 

11.5380

 

 

 

12.5417

 

Euro

 

 

19.2271

 

 

 

20.8555

 

 

Price risk

 

The Group is exposed to the risk of fluctuations in the prices of helium and LNG. The Group manages this risk through the use of contract-based prices with its customers which mitigates the volatility that may arise. As the Group’s operations grow it will consider options available to hedge its price risk exposure and is currently exploring the use of helium tokens under development (see note 4) as one way to manage this risk. At 28 February 2025 the Group’s exposure to price risk is not material (2024: immaterial).

 

The Group is not exposed to equity price risk.

 

Interest rate risk

 

The Group’s interest rate risk arises from the interest-bearing borrowings disclosed in note 14. The DFC and AIRSOL borrowings expose the Group to fair value interest rate risk as they are secured at fixed interest rates. The IDC, Molopo and SBSA borrowings expose the Group to cash flow interest rate risk as they are secured at variable interest rates. The Group manages its interest rate risk by having a balanced portfolio of borrowings at fixed and variable rates, and also by monitoring interest rates on a regular basis.

 

A variation in the interest rate, with all other variables held constant, would impact the Group’s post-tax loss and equity as follows:

 

Figures in Rand Thousands

 

2025

 

 

2024

 

USD borrowings – DFC and AIRSOL

 

A 2% increase in the interest rate

 

 

(13680 )

 

 

(13639 )

A 2% decrease in the interest rate

 

 

13680

 

 

 

13639

 

 

 

 

 

 

 

 

 

 

Rand borrowings – IDC, Molopo and SBSA

 

 

A 5% increase in the interest rate

 

 

(19148 )

 

 

(27710 )

A 5% decrease in the interest rate

 

 

19148

 

 

 

27710

 

 

Management of risk associated with leased assets

 

All lease agreements set out the terms for the use, maintenance, transfer and relocation of leased assets. Tetra4 is responsible for maintaining or appointing a service provider to maintain all leased assets. The relocation of leased assets requires authorisation from Tetra4. The Group also regularly assesses the physical security over all leased assets.

 

Concentration risk

 

The Group is subject to concentration risk as it had two LNG customers (see note 5) during the year ended 28 February 2025. In order to manage concentration risk the Group is in discussions with various potential new customers for the remainder of the Phase 1 LNG production. The Group also has one LHe customer and sales commenced in March 2025.

 

 
62

 

 

33. LOSS PER SHARE

   

 

 

2025

 

 

2024

 

Loss per share

 

Basic and diluted

(cents)

 

(159.10 )

 

 

(75.10 )

Loss attributable to equity holders of Renergen used in the calculation of the basic and diluted loss per share

(R'000)

 

(236120 )

 

 

(110273 )

 

 

 

 

 

 

 

 

 

Weighted average number of ordinary shares used in the calculation of the basic loss per share

(000’s)

 

148412

 

 

 

146833

 

Issued shares at the beginning of the year

(000’s)

 

147529

 

 

 

144748

 

Effect of shares issued during the year (weighted)

(000’s)

 

883

 

 

2 085

 

Add: Dilutive share options

 

 

 

 

 

 

Weighted average number of ordinary shares used in the calculation of the diluted loss per share

(000’s)

 

148412

 

 

 

146833

 

 

The share options and bonus scheme shares have not been included in the weighted average number of shares used to calculate the diluted loss per share or the diluted headline loss per share as they are anti-dilutive. These options are anti-dilutive because of the loss position of the Group.   

             

 

 

2025

 

 

2024

 

Headline loss per share

 

Basic and diluted

(cents)

 

(159.15 )

 

 

(75.07 )

 

 

 

 

 

 

 

 

 

Reconciliation of headline loss

 

 

Loss attributable to equity holders of Renergen

(R'000)

 

(236120 )

 

 

(110273 )

Loss on derecognition of leasing arrangement

(R'000)

 

 

 

 

74

 

Profit on disposal of PPE

(R'000)

 

(120 )

 

 

 

Adjustments attributable to NCI

(R'000)

 

7

 

 

 

(4 )

Tax effects

(R'000)

 

30

 

 

 

(19 )

Headline loss

(R'000)

 

(236203 )

 

 

(110222 )

 

The headline loss has been calculated in accordance with Circular 1/2023 issued by the South African Institute of Chartered Accountants.

 

34. NET ASSET VALUE PER SHARE

 

 

 

 

Note

 

 

2025

 

 

2024

 

Number of shares in issue

 

(000’s) 

 

11

 

 

 

155047

 

 

 

147529

 

Net assets

 

(R’000)

 

 

 

 

 

1114609

 

 

 

1321103

 

Total equity

 

(R’000)

 

 

 

 

 

1114609

 

 

 

1321103

 

Tangible net assets

 

(R’000)

 

 

 

 

 

1090309

 

 

 

1238891

 

Total equity

 

(R’000)

 

 

 

 

 

1114609

 

 

 

1321103

 

Intangible assets

 

(R’000)

 

 

 

 

 

(24300

)

 

 

(82212

)

Net asset value per share

 

(Rand)

 

 

 

 

 

7.19

 

 

 

8.95

 

Tangible net asset value per share

 

(Rand)

 

 

 

 

 

7.03

 

 

 

8.40

 

   

 
63

 

 

35. EVENTS AFTER THE REPORTING PERIOD

 

Commercial LHe sales

 

On 14 March 2025 Renergen announced that Tetra4 had commenced sales of LHe to a customer.

 

Fundraising

 

Renergen has entered into an exclusive arrangement to negotiate a transaction with a third party. As part of those negotiations Renergen has received an initial inflow of US$10 million – US$5 million was received on 1 April 2025 and the balance on 8 April 2025. To the extent the negotiations proceed as planned, additional funding will be extended to Renergen.

  

DFC waiver

 

The DFC provided a default waiver to Tetra4 in April 2025 (see note 14).

 

High court ruling in the Company’s favour against NERSA

 

On 2 May 2025 the High Court found that the Company does not require a NERSA licence for trading in gas (such as methane and helium) when such trading occurs outside the piped gas industry, i.e. not involving the national pipeline grid or downstream market regulated by NERSA. In addition, the judgment clarified that the Gas Act, 48 of 2001 regulates only hydrocarbon gases transported by pipeline, and does not cover noble gases like helium. Thus, helium production and trading are outside NERSA’s regulatory reach.

 

 
64

 

 

36. GOING CONCERN

 

The financial statements presented have been prepared on a going concern basis, which assumes the Group will be able to discharge its liabilities as they fall due. The following circumstances existed as at 28 February 2025:

 

The Group was in default of the terms of the DFC, IDC and SBSA loan agreements. The default events are outlined in note 14 (“Default Events”). Details pertaining to the waivers granted post 28 February 2025 are also contained in this note.

The Group’s current liabilities exceed its current assets by R998.8 million impacted mainly by the classification of the DFC, IDC and SBSA loans as current liabilities as fully set out in note 14.

The Group requires funding for the VGP to complete Phase 1 operations to nameplate capacity and for the development of Phase 2 of the VGP.

 

In conducting its most recent going concern assessment, Management has considered the period up to 30 April 2026 (“Assessment Period”) as it has assessed that the Default Events will be remedied during the Assessment Period and that key funding initiatives will be concluded during this period. The Group has reviewed its cash flow projections for the Assessment Period (“Cash Forecast”) and has performed stress testing of the base case projections. The stress case scenarios include downward variations in the selling prices of LNG and helium (20%), delays in operating at Phase 1 nameplate capacity and a 10% increase in operating costs. Management has also considered volatilities in the exchange rates, interest rates and energy prices in determining the Cash Forecast.

 

The Cash Forecast is underpinned by the following key assumptions:

 

The availability of funding to settle amounts owed to the DFC under the terms of the waiver granted and under the terms of the original agreement. In this regard, to date, the Group has concluded an exclusive arrangement to negotiate a transaction with a third party. As part of those negotiations, in April 2025, the Group received an initial inflow of US$10.0 million (see note 35). To the extent the negotiations proceed as planned, additional funding estimated at US$20.0 million will be extended to the Group.

■ 

The Company’s plans to complete the Nasdaq IPO have not changed and it still anticipates raising R2.9 billion (US$150.0 million) during the Assessment Period. The production and sale of LHe by Tetra4 were key milestones required to provide new investors with the comfort to proceed with this initiative. Shareholder approval for the issue of shares for the Nasdaq IPO was obtained on 11 April 2023; however, the Nasdaq IPO is dependent on market conditions which will determine whether it is completed during the Assessment Period. The Nasdaq IPO is also subject to Securities and Exchange Commission and exchange control approvals, as well as shareholder re-approval in terms of the ASX rules.

The Group expects to obtain debt funding amounting to US$795.0 million from the DFC and SBSA, which includes the refinancing of Phase 1 debt, and is subject to the fulfilment of conditions precedent and other standard conditions. Management is confident that the approvals will be obtained shortly after these conditions are satisfied by the Group.

The Group is also anticipating funding from various funding initiatives, which involve debt, equity and hybrid instruments. These initiatives are also geared towards both alleviating short-term funding requirements as well as long-term commitments.

 

The Group continues to regularly monitor its liquidity position as set out in note 32 as part of its ongoing risk management programme. Various initiatives have come to fruition since 28 February 2025 which have resulted in cash inflows as well as increasing the certainty of future cash inflows including but not limited to the receipt of US$10.0 million as highlighted above.

 

After consideration of the Cash Forecast, the outcome of the stress testing performed and the developments after the reporting date, the Group has concluded that the going concern basis of preparation is appropriate. Management is cognisant of the following material uncertainties that exist which may cast doubt about the Group’s ability to realise its assets and discharge its liabilities in the normal course of business and continue as a going concern:

 

The Group’s ability to conclude the funding initiatives outlined above within the Assessment Period.

The Group’s ability to remedy the Default Events within the times set out in the DFC waiver.

The Group’s ability to secure regulatory and other approvals required to conclude the Nasdaq IPO and other funding initiatives.

 

The Board has a reasonable expectation that funding initiatives and the remediation of Default Events will be concluded within the Assessment Period, and that the approvals required will be obtained. This will enable the Group to have adequate resources to meet its obligations and continue its operations in the normal course of business for the Assessment Period.

 

 
65